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Abstract  
 
Tuberculosis (TB) is a major health problem worldwide resulting in 1.4 million deaths, 
caused by Mycobacterium tuberculosis. Despite all the efforts to target and eliminate 
this chronic disease, the control of tuberculosis has been severely thwarted by the 
emergence of multidrug and extensively resistant strains. The long treatment duration 
and its association with various side effects result in noncompliance of the patients. 
To improve treatment outcomes and reduce duration of therapy, host-directed TB 
therapies could provide a solution for the resolution of the disease. The development 
of host directed therapies will be expedited by further understanding of host-
mycobacterium interaction and how the pathogen hijacks host cell processes to 
facilitate survival. Key to this process is the regulation of host gene expression. 
However, very little is known about translational control by bacterial pathogens, 
including Mycobacterium tuberculosis and how this contributes to pathogenesis. By 
using Mycobacterium bovis Bacillus Calmette-Guerin (BCG) as a surrogate of 
Mycobacterium.tuberculosis, we aimed to dissect how Mycobacterium bovis BCG 
alters translation in the infected macrophages, and how the regulation of eIF4E activity 
participates in this response to infection. Our results suggest that mycobacterial 
infection induces eIF4E phosphorylation in murine macrophages. Furthermore, the 
kinases ERK and MNK are responsible for eIF4E phosphorylation and their activation 
contributes to changes in the translational state of host mRNAs, as identified by 
polysome profiling. These changes alter the macrophage response to mycobacteria, 
affecting intracellular bacterial survival and macrophage viability.  
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As it is believed that in up to 50 % of TB exposed individuals, the infection is cleared 
without the involvement of the adaptive immune system, indicating that the innate 
immune system may be able to control or clear the infection if activated appropriately. 
Further testing of the mechanisms used by macrophages to keep the infection under 
control has been done by measuring TNFα and IL-10 production, phagosomal acidity 
and cellular autophagy in the presence of ERK and MNK inhibitors. We found that the 
activation of ERK-MNK-eIF4E pathway regulates the cytokines production, but only 
ERK plays a regulatory role on macrophage phagosomal acidification as well as cell 
autophagy. Our finding suggests that Mycobacterium bovis BCG benefits from the 
activated ERK-MNK- eIF4E signalling to survive inside the cell. We conclude that 
regulating eIF4E phosphorylation is a key component of the hostpathogen interaction 
during mycobacterium infection and therefore, we suggest the possibility of using 
selective MNK and/or ERK inhibitors as host-directed immuno-therapeutics for 
tuberculosis. 
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1. INTRODUCTION 
1.1. TUBERCULOSIS 
Despite the worldwide use of BCG vaccination and antibiotic treatments, 
tuberculosis (TB) is one of the leading killers among infectious diseases. This disease 
primarily affects the respiratory system and is caused by the bacterium Mycobacterium 
tuberculosis. It is the most successful bacterial pathogen due to its ability to persist in 
infected individuals for years or even decades, in a contained tissue tubercle or nodule 
called a granuloma. The chronic nature of the disease combined with its 
immunopathology implies that M. tuberculosis has developed strategies to evade host 
immune responses and manipulate host cell biology including cell death pathways 
(Behar et al., 2010). 
1.1.1 HISTORY AND EPIDEMIOLOGY 
Tuberculosis is one of the oldest diseases in the world.  Tubercular skeleton 
deformity found in ancient Egypt indicates that TB was present almost 4,000 years 
ago, although it probably coevolved with man since before his emergence from East 
Africa (Smith, 2003).  
In 1882, Robert Koch identified M. tuberculosis as the causative agent of TB. 
During the 19th century, the number of people infected with TB was very high and 
reached a peak, with close to one quarter of the European population dying.  During 
the late 20th century, the death rate declined due to widespread vaccination with BCG, 
the introduction of streptomycin and subsequently other antibiotics, and changes in 
socioeconomic conditions (Daniel, 2005). However, in the mid 1980’s the incidence of 
TB increased due to an association with Acquired Immunodeficiency Syndrome 
(AIDS) (Daniel, 2006). More recently, multidrug resistant (MDR) strains of M. 
Chapter 1                                                                                                    Introduction 
 
19 
 
tuberculosis isolated and it is now estimated that nearly one-third of the world's 
population is infected with M. tuberculosis although the majority of these are 
asymptomatic infections (Jordao & Vieira, 2011).  
In 2014, 1.5 million people died out of 9.6 million individuals diagnosed with 
active TB (World Health Organization (WHO) 2015 report). TB accounts for 
approximately 1.1 million deaths amongst those with Human Immunodeficiency Virus 
(HIV)-negative individuals and 0.4 million deaths for HIV-positive individuals (WHO, 
2015). In addition, over 95% of TB deaths occur in low and middle-income countries 
(Global Tuberculosis Control Report WHO, 2015). Globally, an estimated 3.3% of new 
TB cases and 20% of previously treated cases have MDR-TB. In 2014, an estimated 
190,000 people died of MDR-TB, in which, approximately 9.7% of MDR-TB cases had 
extensively drug resistant TB (XDR-TB) (WHO, 2016). 
Geographically, Africa and Asia have the highest incidence of TB. Meanwhile, 
Southeast Asia and Western Pacific Regions account for nearly 58% of new TB cases 
worldwide. However, Africa carried the most severe burden, with 281 cases per 
100,000 population in 2014, and more than half of the people who developed MDR-
TB were found in India, the People’s Republic of China and the Russian Federation 
(WHO, TB fact sheet, updated 2016). 
With 1.5 million yearly deaths, urgent action is needed to improve control 
strategies. To this end, it will be necessary to develop new vaccines and new more 
effective antibiotics. Gaining a better understanding of the host-pathogen relationship 
is the initial step in achieving these goals. 
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1.1.2 DISEASE STAGES AND CLINICAL MANIFESTATIONS 
The respiratory system is the primary site for the clinical manifestations in the 
TB patient. Other symptoms and signs can occur depending on the different stages of 
the disease that arise after the inhalation of an infected droplet.  The primary stage or 
Ghon’s complex is where M. tuberculosis contained in inhaled aerosols becomes 
implanted in alveoli and the bacteria disseminate to the regional lymph nodes. The 
second stage is the persistence stage or latent tuberculosis, due to a prolonged 
macrophage activity and a massive range of immune mediators, which all lead to 
changes in the lung tissue pathology toward the formation of TB granuloma. The 
patient is usually asymptomatic at these stages. Stage three has been associated with 
the haematogenous spread of the bacilli to the rest of the lung and other organs due 
to disease reactivation and dissemination, namely the disseminated stage or miliary 
tuberculosis. The patient at this stage presents with bloody coughs, chest pain, night 
sweats and weight loss. Other extra pulmonary symptoms and signs are pericarditis, 
meningitis and bone pain which can occur due to disease spread (Smith, 2003). The 
disease progression is affected by many risk factors, such as the age, patient immune 
status and HIV co-infection, depending on the dynamic pathogen-host interaction 
furthermore, the rate of the disease progression is variable and in the majority of cases 
(>90%) occurs within 1 year after the primary infection with greatest risk and rapid 
progression among youngest children. The clinical symptoms associated with primary 
tuberculosis in children depending on the phase of the disease range from viral-like 
fever, meningitis, lymphadenitis and more severe respiratory symptoms (Perez-Velez 
& Marais, 2012). Diagram 1-1 summarize the disease phases in children. 
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Figure 1-1  Clinical phases of tuberculosis in Children. 
 
(A) Shows hillar lymphadenopathy associated with peripheral nodule or Ghon focus. 
(B) Shows a Ghon focus with cavitation, which is seen almost solely in infants and 
immunocompromised children. In (C), enlarged lymph nodes compress the airway, 
causing either complete obstruction with lobar collapse, or partial obstruction leading 
to hyperinflation. (D) Shows necrotic lymph nodes erupting into bronchus leading to 
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endobronchial spread and patchy consolidation. In (E), necrotic lymph nodes 
compress and obstruct the bronchus causing endobronchial spread fissures and the 
formation of focal cavities. (F) Shows diffuse micronodules in both lungs, which may 
result from lymphohematogenous spread after recent primary infection or from the 
infiltration of a necrotic lymph node or lung lesion into a blood vessel, leading to 
hematogenous spread. (G) Shows a pleural effusion that is usually indicative of recent 
primary infection, (H) shows a pericardial effusion that occurs when tuberculoprotein 
leaks into the pericardial space; it may also occur after hematogenous spread. (I) 
shows cavity formation in both upper lobes. Nodules or cavities in apical lung 
segments are typical of adult-type disease and are pathologically distinct from the 
other cavities shown. Taken from Perez-Velez CM et al 2012. 
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1.1.3 DISEASE DIAGNOSIS AND TREATMENT  
The lack of accurate and rapid diagnostics for TB remains a major obstacle in 
the disease control efforts, especially in areas with high HIV infection and anti-
tuberculosis drug resistance cases. Amazingly, the global case detection rate for TB 
from 2014 is approaching the goal of 70 %. The diagnosis of tuberculosis mainly relies 
on sputum smear microscopy and chest radiology in low and middle income countries. 
Other immunological based methods as tuberculin skin test and more specific IFN-γ 
release assays, phage amplification assays, solid culture and automated liquid culture 
are also being used for disease diagnosis (Lawn et al., 2015, Lessells et al., 2015).  
The standard first-line treatment regimen consists of two months of isoniazid, 
rifampicin, pyrazinamide and ethambutol followed by four months of isoniazid and 
rifampicin. These drugs are effective against actively replicating bacilli rather than the 
non- or slowly replicating ones present in latent TB infection. Therefore, to treat latent 
TB infection and multidrug resistant tuberculosis (MDR-TB), a longer treatment 
duration is required (between 9 to 18 months) and the second group of drugs, 
fluoroquinolone, is included in the treatment regimen. The current treatment can 
achieve 70-80% success rates in MDR-TB. In a number of patients, combining the 
treatment with the surgical removal of the infected tissue increases the success rate 
up to 80-90% (Caminero et al., 2010, Lee et al., 2015). 
 In addition, other host directed immune modulator drugs have been used to 
minimize the tissue damage and improve the disease resolution. These adjunctive 
therapy include corticosteroids and anti TNFα have been introduced in combination 
with the current TB treatments (summarized in Kiran et al., 2016). 
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1.1.4 DISEASE TRANSMISSION AND PATHOGENESIS   
TB is transmitted from person to person through the inhalation of aerosol 
droplets containing viable bacilli discharged into the atmosphere by other persons with 
active infection. The bacilli settle on to the surface of alveoli and are engulfed by local 
phagocytes, called alveolar macrophages. These phagocytes migrate in to the 
parenchyma of the lungs and trigger the innate immune response further which leads 
to the subsequent activation of the adaptive immune response (Griffiths et al., 2010). 
Within two to six weeks of infection, cell-mediated immunity (CMI) develops, followed 
by an influx of lymphocytes and activated macrophages into the lesion resulting in 
granuloma formation. This granuloma consists of macrophages in the centre 
surrounded by lymphocytes. The cellular microenvironment entraps the bacilli and in 
most cases averts the spread of mycobacterium.  However, the granuloma is also the 
means by which the bacteria is transmitted as breakdown of this immune 
microenvironment will promote bacterial replication and may facilitate the release of 
the bacilli into the airways from where may be aerosolised by coughing (Figure 1-2) 
(Luisa & Vieira, 2011).  
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Figure 1-2 Mycobacterium tuberculosis (Mtb) life cycle. 
. 
Mycobacterium tuberculosis (Mtb) infection starts with the inhalation of bacilli, followed 
by deposition of the bacteria in the lung. The main host for the bacilli are resident 
alveolar macrophages (Φ). The phagocytosis of M. tuberculosis by alveolar 
macrophages leads to recruitment of immune cells. The bacteria are taken up by 
dendritic cells (DCs), which carry M. tuberculosis to the draining lymph nodes to trigger 
innate immune response and activate cellular migration from the lymph node to reach 
back to the site of inflammation under the influence of chemokines and other 
mediators, leading to containment of the infection inside the granuloma. The rupture 
of granuloma provokes disease reactivation and dissemination of infection (adapted 
from Russell, 2007). 
 
 
Chapter 1                                                                                                    Introduction 
 
26 
 
1.1.5 HOST IMMUNE RESPONSE AGAINST M. TUBERCULOSIS 
 
1.1.5.1 INNATE IMMUNE RESPONSE 
The innate immune response plays a central role in the protection against M. 
tuberculosis as it provides the first line of defence against the invading pathogen.  
Macrophages and neutrophils are the main effector cells of the innate immune system. 
However, because of the evolved strategies of M. tuberculosis to manipulate the 
macrophage to allow intracellular survival and replication, the innate immune system 
is also a prerequisite for mycobacterial pathogenesis.  
 
1.1.5.2 MACROPHAGE ACTIVATION AND ITS ANTIMICROBIAL ACTIVITY 
Macrophages are a critical component of the innate and adaptive immune 
response to bacterial pathogens. The activation of macrophages during infection with 
an intracellular pathogen induces a complex series of interactions involving many cells 
of both the innate and specific immune system and their secreted products. This 
activation is critical in rendering the macrophage competent to kill the intracellular 
pathogen and therefore recovering from the infection. This is accomplished through 
the diverse functions of macrophage including activation of inflammatory pathways, 
the recruitment of immune cells to the site of infection, formation of phagosome and 
the production of antimicrobial peptides. However, macrophages have the ability to 
induce cell death signaling pathways if the previous mechanisms have failed to 
eliminate the microbe. This can function as a direct deprivation of the replication niche 
of the bacterium or virus, and provide a signal to the remaining immune system 
(Lamkanfi et al., 2010).  
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An additional mechanism is autophagy, a process that maintains cellular 
homeostasis by which, the cell cytoplasmic portions get sequestered in a membrane 
compartment and degraded through a pathway similar to that of phagosomal 
maturation. This process has been implicated in enhanced killing of intracellular 
pathogens including M. tuberculosis (Deretic et al., 2005, 2009). 
 
1.1.5.3 MACROPHAGE RECOGNITION OF MYCOBACTERIA BY PATHOGEN 
RECOGNITION RECEPTORS 
As many other pathogens, M. tuberculosis is recognized by host receptors 
called pathogen recognition receptors (PRRs) including Toll-like receptors (TLRs) and 
non-TLRs. These are proteins expressed on the surface or in the cytoplasm of 
macrophage to recognize the bacterial product called pathogen–associated molecular 
pattern (PAMP) and induce innate immune responses. Many of these receptors have 
been described to mediate the uptake of mycobacterium and facilitate the process of 
phagocytosis. Binding of PAMP to the mannose receptor and DC-SIGN have been 
reported to provide signals to the host cell to promote anti-inflammatory cytokine IL-
10 production (Hossain & Norazmi, 2013). The uptake of mycobacterium by the 
complement receptor (CR3) and scavenger receptor bacterial trigger a minimal 
superoxide production and low pro-inflammatory response (Schlesinger et al., 1990, 
1998, Korbel et al., 2008). 
Another group of PRRs relevant to mycobacteria are TLRs and there are 
usually located on the cell surface. These proteins are type I trans-membrane proteins 
composed of an extracellular domain containing Leucine Rich Repeats (LRR), which 
recognize specific PAMPs, a transmembrane domain and a cytoplasmic domain with 
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great homology to the IL-1 receptor. TLRs include 10 highly conserved members each 
of them recognizes a distinct microbial product for example LPS by TLR4, lipoproteins 
by TLR2 and double stranded viral RNA by TLR3 (reviewed by Takeuchi & Akira, 2010, 
Mortaz et al., 2015). 
The most important TLR involved in recognition of mycobacteria is TLR2 which 
recognises numerous glycolipids associated with the cell wall as well as lipoproteins 
(Hossain & Norazmi, 2013). The binding of PAMPs to TLR leads to signal transduction 
events and promotes nuclear translocation of NF-κB. In the resting cell, the 
heterodimer form of NF-κB, consisting of its p50 and p65 components, remains in the 
cytoplasm because of its interaction with inhibitory κB proteins (IκB). As a 
consequence of TLR stimulation, a series of phosphorylation events leads to poly-
ubiquitination and degradation of IκB. The freed NF-κB can move to the nucleus, bind 
to the DNA and initiate the transcription of several pro-inflammatory cytokine genes 
(Takeda & Akira, 2004). Other signalling PRRs are nucleotide-binding and 
oligomerisation domain-like receptors (NOD-like receptor NLR) such as NOD1 and 
NOD2. In TB infection both NOD2 and TLR2 act synergistically and activate NF-κB 
signalling pathway leading to cytokine production (Korbel et al., 2008).  
The pro-inflammatory mediators promoted by NF-κB activation include 
cytokines TNFα, IL-1, IL-6, IL12, IL-18 and chemokines, which attract more dendritic 
cells DC, macrophages, neutrophils and NK cells. In contrast, interleukin-10 (IL-10) 
exerts its anti-inflammatory activity in part through the inhibition of NF-κB by blocking 
IκB kinase activity and by inhibiting nuclear NF-κB, therefore down regulating pro-
inflammatory cytokines (Driessler et al., 2004, Bai et al., 2013). The timing of pro-
inflammatory and anti-inflammatory cytokines release is tightly regulated and is crucial 
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for controlling the M. tuberculosis infection and limiting host tissue damage (Murray et 
al., 2014). 
 
1.1.5.4 THE ROLE OF MACROPHAGES IN GENERATING AN ADAPTIVE 
IMMUNE RESPONSE  
         Macrophages and infected DC present M. tuberculosis-antigens on MHC class I 
to CD8+ cytotoxic T lymphocytes, and through MHC class II to CD4+ T helper cells. 
This leads to the activation and proliferation of the lymphocytes. The CD4+ T helper 
cells can be differentiated into Th1, Th2, Th17 and regulatory T cells (Treg), which 
orchestrate the immune response to the pathogen (Dheda et al., 2010). 
  A Th1 response leads to the release of pro-inflammatory cytokines (IL-12, IL-
18, IFN-γ) and has been associated with control of mycobacterial infection. IFN-γ is 
thought to enhance the destruction of intracellular mycobacteria by activating 
macrophages to efficiently fuse hydrolytic lysosomes to the mycobacterial phagosome 
and by stimulating synthesis of nitric oxide NO and reactive oxygen species (ROS) 
(Flynn &Chan, 2003). On the other hand, a Th2 response results in the release of IL-
4, IL-5, IL-10 and IL-13 which promote B lymphocyte activation causing an antibody 
response and promotes an anti-inflammatory macrophage response (Kaufmann, 
1993, 2001). This is generally considered to be non-protective against mycobacterial 
infection (Potian et al., 2011).  
In addition, Th17 cells stimulated by IL-23, IL-6, IL-21, and low TGF-β levels, 
are involved in recruitment of neutrophils and monocytes to the site of infection and 
secrete IL-17. Regulatory T cells (Treg) produce anti-inflammatory cytokines such as 
IL-10 and TGF-β which cause the suppression of inflammatory macrophage 
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responses. Its activity is elevated in TB patients (Dheda et al., 2010) (Morris et al., 
2013). CD8+ cytolytic T cells (CTL) secrete a perforin and granulysin, which induces 
the lysis of M. tuberculosis-infected cells by the induction of apoptosis through the 
extrinsic pathway via Fas ligand (Canaday et al., 2001).  
 
1.1.6 M. TUBERCULOSIS SURVIVAL STRATEGY INSIDE MACROPHAGE 
Despite the nature of this cell type and its bactericidal characteristics and 
functions, the macrophage is the main replication niche of M. tuberculosis. Therefore, 
the bacillus has evolved several strategies for surviving in the hostile intracellular 
environment of the macrophage.  
 
1.1.6.1 INHIBITION OF PHAGOSOMAL MATURATION BY M. TUBERCULOSIS  
In order to survive, several pathogens such as Listeria and Shigella subspecies. 
escape into the cytoplasm to avoid the degradative milieu of the lysosome. Coxiella 
and Leishmania subspecies. can replicate inside phago-lysosomes despite the hostile 
milieu. In contrast, Legionella, Brucella and Mycobacterium subspecies. inhibit 
phagosomal maturation (Rohde et al., 2007). There are several ways in which M. 
tuberculosis manipulates the macrophage phagolysosome formation. Within minutes 
after macrophage phagocytosis of a particle, the phagosome undergoes a series of 
fusion and fission events to deliver lysosomal hydrolases and recruit vacuolar H+-
ATPases, which allow phagosome maturation. The main phagosome antimicrobial 
features are acidification of phagosome, activation of NADPH oxidase (NOX2) and 
activation of iNOS (Flannagan et al., 2009). However, the M. tuberculosis (Mtb) 
phagosome preserves the properties of an early phagosome such as the relatively 
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high pH 6.4, retention of early endosome markers like Rab5 and continued access to 
recycling endosomes (Via et al., 1997, Deretic et.al, 2006) (Figure 1-3).  
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Figure 1-3 Mycobacterium phagosome maturation arrest. 
 
Phagosomes containing M. tuberculosis only acidify to pH 6.4, and fail to fuse with 
lysosomes. The vacuoles containing M. tuberculosis retain many of the characteristic 
of the early endosomal system (adapted from Russell, 2007). 
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Several mechanisms have been suggested to contribute to this inhibition of 
phagosome maturation mycobacterial infection. Mannosylated lipoarabinomannan 
(ManLAM), is a mycobacterial cell wall glycolipid that sheds of the bacterium upon 
entry into the cell, can be found throughout the macrophage membrane. In 2007, 
Hayakawa et.al found that ManLAM can physically obstruct membrane fusion and 
interfere with the membrane raft composition (Hayakawa et al., 2007). Other studies 
have shown that ManLAM can inhibit the recruitment of early endosomal antigen 1 
(EEA1), which is necessary for subsequent fusion and fission events that lead to the 
delivery of lysosomal hydrolases and vacuolar H+-ATPases to the phagosome. The 
inhibition of EEA1 recruitment is completed either through the prevention of calcium 
(Ca2+) flux in the cytoplasm which is necessary for calmodulin- and Ca2+/calmodulin-
dependent kinase II (CaMKII)-dependent delivery of EEA1(Malik et al., 2000, 2001, 
2003) or through the blockage of PI3P (Vergne et al., 2004). This blockage is thought 
to happen through ManLAM-mediated inhibition of the PI3K hVPS34 as well as 
through SapM-mediated dephosphorylation of PI3P (Gonzalo-Asensio et al., 2008). 
Additional mechanisms for phagosome maturation inhibition are the 
phosphorylation of an unknown host substrate by the serine/threonine kinase PknG, 
regulating phagosomal maturation (Rohde et al., 2007). In addition, the activation of 
the MAPK p38 by M. tuberculosis, leading to reduced Rab5 activity and thus reduced 
EEA1 on phagosomes (Fratti et al., 2003). Finally, the maturation of the phagosome 
is affected by retention of a molecule on the phagosome membrane termed coronin 1 
that is involved in Ca2+ signalling (Pieters, 2008).  
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The mechanisms described above all result in a phagosomal compartment that 
is deficient in microbial killing due to the lack of acidification and the absence of mature 
lysosomal hydrolases. 
 
1.1.6.2 EVASION OF CELLULAR AUTOPHAGY BY M. TUBERCULOSIS  
Autophagy is a fundamental cellular homeostatic process whereby cytoplasmic 
macromolecules get sequestered in a double membrane vacuoles and delivered to 
lysosomes for degradation. It is a cell survival/death pathway used by eukaryotic cells 
to recycle cellular components and adapt the environmental stress as well as 
nutritional deprivation and infection. This process occurs in all mammalian cells to 
clear up, or recycle, the damaged organelles. It has become evident that autophagy 
plays a key role in aging, inflammatory disease and innate immunity to infection. The 
impairment of autophagy has also been associated with cancer (Kundu et al., 2008).  
As a part of innate immune response, autophagy helps to remove the 
intracellular pathogens (Deretic, 2005b), as well as its role in adaptive immunity 
enabling antigen processing for MHC II presentation (Munz, 2016). During the process 
of autophagy, a damaged organelle of the cytosol becomes sequestered by a nascent 
autophagosomal isolation membrane (phagophore). Next, the phagophore enlarges 
by the addition of new membrane (elongation) and seals to form a specialized 
phagosome. Auto phagosomes are distinguished from the conventional phagosomes 
by the presence of a double membrane delimiting the lumen. Finally, a fusion between 
the autophagosomes and lysosomes forms a degradative compartment called the 
autolysosome (Deretic, 2005). 
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Autophagy has been implicated as a powerful mechanism in removing 
intracellular M. tuberculosis, which is induced by the p47 family of GTPases. This 
family is inducible by IFN-γ and has been implicated in defense against intracellular 
M. tuberculosis pathogens (Gutierrez et al., 2004). Th1 cells secrete IFN-γ as a 
defence mechanism against M. tuberculosis infection and this mediates autophagy 
and suppress intracellular M. tuberculosis survival. However, M. tuberculosis is able 
to inhibit IFN signalling, likely by the chronic stimulation of TLR2 by ManLAM and thus 
the inhibition of its sequestration into autophagasomes. 
 
1.1.6.3  INHIBITION OF HOST CELL DEATH PATHWAYS BY 
M.TUBERCULOSIS. 
Controlling cell death by the host during viral or bacterial infection is an 
important infection defence mechanism. However, modulation of host cell death 
pathways by pathogens can also be considered as a virulence factor and a component 
of the pathogen survival strategy. The change of death modality of the host cell and 
the timing of cell death can affect the outcome of the disease and the ability of the host 
to eliminate the infected cell and the microbe. 
M. tuberculosis infection induces apoptotic and necrotic cell death where both 
play a significant role in disease pathogenicity. Apoptosis (programmed cell death) 
involves activation of a group of protein proteases called caspases. These are 
categorized into initiator caspases (caspase-2, -8, -9, and -10) and executioner 
caspases (caspase-3, -6, and -7). Apoptosis can be induced through the extrinsic or 
intrinsic pathway (Lamkanfi et al., 2010) 
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The intrinsic pathway is activated in cellular stress that leads to DNA-damage 
induced by cancer chemotherapy, radiation and some microbial infections. Bax and 
Bak are activated through inhibition of anti-apoptotic Bcl-2 by Bcl-2-homology 3 (BH3)-
only proteins, leading to a decrease in mitochondrial membrane potential and 
cytochrome c release. Cytochrome c forms the apoptosome complex together with 
apoptosis protease activating factor-1 (Apaf-1) that mediates the activation of 
caspase-9. Thereafter, activated caspase-9 promotes activation of downstream 
effector caspases and the induction of apoptosis (Lee et al., 2009, Lamkanfi et al., 
2010). While in the extrinsic pathway the ligation and oligomerization of death 
receptors by their ligand (TNF, Fas ligand, and TRAIL) induces the assembly of the 
death-inducing signalling complex (DISC), and activation of caspase-8 and -10 (Lee 
et al., 2009, Lamkanfi et al., 2010) (Figure 1-4).  
Necrosis is a cell death mode that is associated with excessive inflammation 
leading to detrimental tissue damage, cellular swelling and DNA fragmentation. It was 
long thought to be an accidental uncontrolled type of death that does not involve 
cellular signalling. However, it is becoming increasingly evident that necrosis follows 
a programmed basis, when there is a failure in induction of caspase activation 
(Lamkanfi et al., 2010). This can lead to activation of the serine/threonine kinases 
receptor interacting with proteins RIP1 and RIP3 then subsequent ROS production, 
calpain activation, destabilization of lysosomes and the release of cathepsins (Chan 
et al., 2003, Lamkanfi et al., 2010) (Figure 1-4). 
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Figure 1-4 Apoptotic versus Necrotic cell death. 
 
An illustration of the major cell death pathways in macrophages, including apoptosis 
and necrosis. The cell death types are characterized by morphologic, biochemical, 
enzymologic, functional and immunological features (adapted from Lamkanfi et al., 
2010). 
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The other types of cell death that involve mitochondrial damage are mediated 
by BAX or BAK, and include lysosomal apoptosis, pyroptosis and pyronecrosis. 
Lysosomal apoptosis is induced by oxidative stress followed by lysosomal membrane 
permeabilization, which in turn induces lysosomal proteases (cathepsins) release to 
the cytosol, and then triggers programmed cell death. Pyroptosis and pyronecrosis are 
inflammasome-related cell death. Pyroptosis is a caspase-1-dependent cell death. 
Unlike necrosis but similar in the morphological feature of apoptosis, it is associated 
with IL-1b and IL-18 production which elicits more inflammatory responses than 
necrosis (Lamkanfi et al., 2010).  
 
Amongst the previously mentioned cell death modalities, some are documented 
in relation to M. tuberculosis infection. Several studies have demonstrated that virulent 
M. tuberculosis inhibits apoptosis and induces necrotic cell death (Zhang et al., 2005, 
Chen et al., 2006), whereas avirulent mycobacteria are potent stimulator of apoptosis. 
(Keane et al., 2000). Furthermore, individual M. tuberculosis genes involved in 
apoptosis inhibition have been discovered, such as nuoG and secA2 (Lee et al., 2009).  
However, other studies contradict this model of apoptosis inhibition by M. 
tuberculosis. One study conducted by Butler et al, 2012 concludes that bacterial 
virulence is not the only determining factor in the mechanism of cell death. Factors 
such as bacterial load, cell cytotoxicity and the period of infection can also affect the 
mode of cell death. Other host related apoptosis inhibitory mechanisms can include 
ligation of TLR2 and stimulation of TNF-R2 release. By reducing the availability of bio-
active TNFα and through the upregulation of host anti-apoptotic proteins such as Mcl-
1 and Bcl-2 family member bfl-1/A1, this can alter the balance between the apoptotic 
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and necrotic cell death of M. tuberculosis (Ren et al., 2010). Another mechanism 
demonstrated by Martin et al, 2012 to enhance the mycobacterial killing is 
efferocytosis, in which mycobacterium containing apoptotic bodies are taking up the 
surrounding non infected macrophages. 
Overall, this exemplifies the many strategies that mycobacteria have evolved 
to manipulate cell death pathways.  
 
1.1.7  M.BOVIS BCG AS A SURROGATE MODEL OF M.TUBERCULOSIS  
        The M. tuberculosis species complex (MTC) contains a number of closely related 
pathogens including M. tuberculosis, M. bovis, M. africanum, M. canettii and M. bovis. 
The Bacille Calmette-Guérin (BCG) vaccine strain was developed from virulent 
Mycobacterium bovis, by repeated sub-culturing over years until it become attenuated. 
The genomes of M. bovis BCG and M. tuberculosis show a high degree of homology, 
sharing 99.9% of their DNA (Mattow et al., 2001).  
Although, M. bovis BCG mimics M. tuberculosis in which it survives 
phagocytosis by macrophages and elicits protective immunity in animals. 
Furthermore, because M. bovis BCG is a category 2 pathogen (as opposed to M. 
tuberculosis and M. bovis which are category 3), researchers have been using M. 
bovis BCG as a model organism to study host-pathogen relationship during 
tuberculosis. The process of M. bovis vaccine strain propagation leads to deletion in 
RD1 genome sequence that impacts on M. bovis virulence gene. Despite the lake of 
some virulent antigenicity, M. bovis BCG retains its ability to survive within the 
macrophage. 
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Findings made with M. bovis BCG will eventually need to be corroborated in M. 
tuberculosis and/or M. bovis while M. bovis BCG vaccine strain is used as a model 
organism for the current study. 
 
1.2 REGULATION OF PROTEIN SYNTHESIS  
 
Cells within the body respond to environmental stimuli and pathogen infection 
in many ways, the most common of which is via the regulation of gene expression. 
The expression of the information stored in within genes is tightly controlled to ensure 
that the correct protein is produced at the right time and quantity. The proteins define 
the properties and functions of cells and importantly, changes to proteins in our cells 
help to fight against invading pathogens. The regulation of gene expression can occur 
at many stages including transcription, mRNA processing and turnover, mRNA 
translation, and post-translational protein turnover. The control of gene expression in 
eukaryotes at the mRNA translation level is critical for cellular proliferation, 
development, differentiation and death.  
Infections have multiple effects on the host cell. Upon infection, the cellular 
transcriptional profile is often altered to favour pathogens spread or persistence. In 
addition to changes seen in genes involved in the host response to infection, the 
modification of cellular transcription leads to increased expression of proteins involved 
in pathogens replication or the synthesis of inhibitors of the immune response. To 
further antagonize the host defence, many pathogens impair general cellular 
translation by manipulating the activity of the protein synthesis machinery, although to 
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date most studies have dissected how viruses, rather than bacteria, contribute to these 
processes (Mohr et al., 2012). 
Translation or protein synthesis is an energy consuming process. It begins after 
exporting the mRNA from the nucleus into the cytoplasm through the nuclear pores, 
to be loaded on the ribosomes. This process generates proteins by decoding the 
instructions contained within the messenger RNA (mRNA) sequence, which is 
translated by the ribosome. Ribosomes are composed of ribosomal RNAs and 78 
different proteins.  These proteins are subdivided into two subunits: A 40S and a 60S. 
To impact on the quantity and quality of proteins made, all the phases of translation 
can be regulated. Translation (protein synthesis) is divided into four phases: initiation, 
elongation, termination and recycling (Sonenberg et al., 2009, Dever et al., 2012). 
 Initiation: is a rate-limiting step in translation, requiring a large numbers of 
cellular host factors to recruit the ribosomal subunits and assemble ribosomal 
complexes onto the cognate start codon in the P-site of the ribosome. 
 Elongation: corresponds to the recruitment aminoacylated–tRNA and the 
peptidyl transfer reaction to build the polypeptide chain.  
 Termination:  occurs when stop codon enters the A site of the ribosome, which 
promotes the release of the nascent polypeptide chain from ribosome. 
 Ribosomal Recycling: is the dissociation of mRNA and ribosomal subunits, 
allowing them to be ready for another round of protein synthesis. 
  Several intracellular signalling pathways act at different steps of initiation to 
control translation. This forms the core topic of my thesis work and will be 
discussed in detail in the next sections. 
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1.2.1 TRANSLATION INITIATION MECHANISMS  
The eukaryotic translation initiation is performed by the coordinated action of 
ribosomes, translation initiation factors (eIFs), as well as the initiator Met–tRNAiMet 
ATP and GTP to form elongation-competent 80S ribosomes (Pestova et al., 2007, 
Jackson et al., 2010, Rodnina, 2015). 
Translation is a cyclic process, and ribosomal subunits that participate in 
initiation derive from the recycling of post-termination ribosomal complexes (post-
TCs). Post-TCs, comprising of an 80S ribosome bound to mRNA, P-site deacylated 
tRNA and eukaryotic release factor 1 (eRF1), are recycled by releasing these ligands 
and dissociating ribosomes into subunits. The 40S ribosomal subunit then binds eIF1, 
eIF1A, eIF3, eIF5 and the eIF2 ternary complex (eIF2-GTP-Met–tRNAiMet) to form a 
43S pre-initiation complex. The eukaryotic initiation factor 4 F (eIF4F) is a multiprotein 
factor responsible for the recruitment of the 40S ribosomal subunit to the mRNA 5’ 
end. This is comprised of the cap-binding protein eIF4E, the large scaffolding protein 
eIF4G and the DEAD-box RNA helicase eIF4A (Merrick, 2015). The eukaryotic 
initiation factor 4E (eIF4E) binds the 7-methylguanosine cap structure at the 5' end of 
messenger RNA. The structure of eIF4E resembles a cupped hand, with the concave 
surface of the protein binding to the cap, while the convex surface interacts with eIF4G 
and enhance its binding to the cap. Eukaryotic initiation factor 4G (eIF4G) is a large 
protein with a molecular weight of 220-kDa. Two isoforms eIFGI and eIFGII are 
produced and share approximately 46% of each identity (Prevot et al., 2003). eIF4F 
binds to the 5’ terminal cap of mRNA, via the cap-binding protein eIF4E and to the 3' 
end of the mRNA onto the polyA binding protein (PABP) via eIF4G thus circularizing 
the mRNA into a closed-loop structure. 
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Following cap recognition, eIF4F-bound mRNA and eIF3 cooperatively recruit 
the 43S pre-initiation complex. The 43S pre-initiation complex then scans the mRNA 
5’ untranslated region (5’ UTR) in the 5’ – 3’ direction in an ATP-dependent manner. 
During this process, eIF4A is involved in unwinding the secondary structure within the 
5’-untranslated region (5`UTR) of the mRNA. It consists of two domains that act as 
clamps and alternate between an inactive ‘open’ and an active ‘closed’ conformation, 
in which both domains form a contiguous RNA-binding surface with the ATP-binding 
site. Its helicase activity is strongly enhanced by eIF4G and eIF4B (or eIF4H) binding, 
preventing mRNA re-annealing and promoting unidirectional eIF4A movement 
(Rogers et al., 2001). Eventually, eIF4A dissociates from mRNA, however, being 
anchored to its 5’ end by the eIF4E–cap interaction to resume another cycle of 
unwinding. This allows the 5’-proximal region constantly prepared for ribosomal 
attachment that is likely facilitated by the eIF3–eIF4G interaction (Jackson et al., 
2010). During scanning, eIF1 and eIF1A ensure the fidelity of initiation by maintaining 
the 40S mRNA decoding channel in an open position and preventing the premature 
hydrolysis of eIF2-bound GTP in 43S complexes and subsequent Pi release 
(Passmore et al., 2007). This overall maintains the ribosome in a scanning-competent 
conformation. Upon recognition of the cognate AUG start codon and codon-anticodon 
base paring in the 40S P-site, 48S initiation complexes assemble. 
Subsequently, eIF5, a GTPase-activating protein (GAP) promotes the 
hydrolysis of eIF2-bound GTP and the dissociation of bound factors. Another GTPase, 
eIF5B, through its interaction with eIF1A C-terminal domain, mediates the recruitment 
of the 60S subunit and displacement of the remaining eIFs (Acker et al., 2006). This 
interaction between eIF1A-eIF5B promotes release of eIF1A from the 80S initiation 
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complex to open up the A-site for the first aminoacyl-tRNA (Fringer et al., 2007). This 
completes the initiation phase leaving the initiator tRNA in the P-site of an elongation-
competent complex (Pestova et al., 2007) (Figure 1-5).  
This process is a rate-limiting step and therefore is under tight regulation. For 
example: stress, viral infection, or cancer, can all affect translation initiation via the 
activation of cell signalling cascades. 
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Figure 1-5 Eukaryotic mRNA translation initiation pathway. 
 
This pathway is divided into stages; pool of 40S and 60S ribosomal subunits were 
recycled from the separation of post-termination complex, 40S binds to eIF2•GTP/Met-
tRNAMeti ternary complex to form 43S pre-initiation complex with eIF1, eIF1A, eIF3 and 
probably eIF5. Attachment of the 43S complex to activated mRNA through eIF4F 
complex, and start scanning of the 5’UTR in a 5’→3’direction by 43S complexes. 
Recognition of the initiation codon switches the scanning complex to a ‘closed’ 
conformation and leads to displacement of eIF1, permitting eIF5-mediated hydrolysis 
of eIF2-bound GTP and Pi release. Joining of 60S subunits to 48S complexes are 
followed by release of initiation factors (eIF1, eIF3, eIF4B, eIF4F and eIF5), which 
mediated by eIF5B. All leading to the assembly of elongation-competent 80S 
ribosomes (adapted from Mohr, 2005). 
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1.2.2 REGULATION OF EUKARYOTIC INITIATION FACTORS AND 
INTRACELLULAR SIGNALLING 
1.2.2.1 eIF2 AND REGULATION OF THE TERNARY COMPLEX 
The eukaryotic initiation factor 2 (eIF2) is a heterotrimer comprising of the α, β 
and  subunits. eIF2 binds to the initiator Met–tRNAiMet and GTP, to form a stable eIF2-
GTP-Met–tRNAiMet ternary complex (TC). eIF2α is the regulatory subunit, eIF2β binds 
the initiator tRNA and eIF2 binds GTP. Upon the recognition of the start codon on the 
translating mRNA, as the base pairing between the anticodon of Met–tRNAiMet and an 
AUG codon takes place, GTP hydrolysis by eIF2 is triggered by eIF5. Thereafter, eIF2 
is released as a binary complex with GDP. eIF2-GDP is recycled into eIF2-GTP by 
eIF2B, which acts as a guanine nucleotide exchange factor (Jackson, 1991, Proud, 
1992, Sonenberg et al., 2003) (Figure 1-6). 
eIF2α is a key target in translational regulation. Phosphorylation of eIF2α on 
Ser 51 converts eIF2 from a substrate to a competitive inhibitor of its exchange factor, 
eIF2B. This phosphorylation is regulated by four cellular stress-activated protein 
kinases. Heme-Regulated Kinase (HRI), activated by unbalanced synthesis of heme 
and globin in erythroid Cells. The double stranded RNA (dsRNA)-activated protein 
kinase PKR is triggered by the presence of double-stranded RNAs commonly present 
during viral infections as replication intermediates. PKR-like endoplasmic reticulum 
kinase (PERK) is a trans-membrane endoplasmic reticulum enzyme, and is activated 
by the presence of miss-folded proteins leading to ER stress. Finally, General Control 
Non-Depressible 2 (GCN2) is activated by amino acid deprivation (Dever et al., 2007, 
Jackson et al., 2010). 
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The phosphorylation of eIF2 inhibits the recycling of eIF2 into its active GTP-
bound form and thereby reduces global translation. This allows cells to conserve 
resources and initiate a reconfiguration of gene expression to effectively manage 
stress conditions (Wek et al., 2006). The inhibition of global protein synthesis is 
concomitant with the induction of translation of selected mRNA such as transcriptional 
activator factor 4 (ATF4). ATF4 mRNA contains two uORFs and an ATF4-coding 
region. In the resting state, the uORF1 allows scanning and re-initiation at downstream 
coding regions in ATF4 mRNA. While in cellular stress, the increased level of eIF2α 
phosphorylation increases the duration of the scanning ribosomes to become 
competent to re-initiate translation. This delayed re-initiation allows for ribosomes to 
scan through the inhibitory uORF2, and instead re-initiate at the ATF4-coding region 
(Wek et al., 2006). ATF4, with other transcriptional regulatory proteins, regulates gene 
expression of genes involved in amino acid transport, and regulates resistance to 
oxidative stress, cell signaling and apoptosis (Harding et al., 2003). 
Increased ATF4 expression induces ATF3, which is required for enhanced 
expression of CHOP. Both ATF3 and CHOP also enhance the expression of GADD34, 
which is required for the eIF2α dephosphorylation by targeting the type 1 
serine/threonine protein phosphatase. These transcriptional regulators with other 
basic leucine zipper (bZIP) proteins regulate expression of a large number of genes 
involved in metabolism and amino acid transport, the redox status of the cell, signaling 
and transcription, and apoptosis. eIF2 phosphorylation can also lead to activation of 
stress-related transcription factors, such as NF-κB (nuclear factor κB), by lowering the 
levels of its regulatory protein IκB (inhibitor of NF-κB). NF-κB regulates transcription 
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of genes involved in immune and inflammatory responses, cell growth and apoptosis 
in response to stress such as viral infection (Wek et al., 2006). 
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Figure 1-6 Regulation of translation by of eIF2 phosphorylation. 
 
Eukaryotic translation initiation factor 2 (eIF2) forms a ternary complex with GTP and 
the initiator tRNA (tRNAiMet) to participate with 40S ribosomal subunit in the scanning 
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of the mRNA and start codon recognition. Upon the assembly of the 80S complexes, 
GTP bound with eIF2 is hydrolysed into GDP, and eIF2–GDP is released from initiation 
complexes. The GDP-bound eIF2 is recycled to the active eIF2–GTP by a reaction 
catalysed by the guanine nucleotide-exchange factor, eIF2B. Phosphorylation of 
eIF2α subunit at Ser51 by stress activated protein kinases alters eIF2 from a substrate 
to an inhibitor of eIF2B, and prevents the recycle of eIF2–GDP to its active GTP bound 
form leading to translation initiation inhibition (adapted from Mohr, 2005). 
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1.2.2.2 REGULATION OF eIF4E AVAILABILITY 
The regulation of eIF4E availability and activity in response to stress such as 
DNA damage, hypoxia and nutrient availability (provoked by infection, cancer and 
irradiation), facilitates a rapid change in specific cellular mRNA translation. The activity 
of the cap binding protein eIF4E is also regulated through its interaction with the 
repressor proteins called eIF4E binding proteins (4EBPs) (Musa et al., 2016). eIF4E- 
binding proteins 1, 2 and 3 (4E-BP1, 2, 3) are a family of small (10–12 kD) acidic 
proteins that interfere with the assembly of the eIF4F complex (Pause et al., 1994). 
Hypo-phosphorylated 4E-BPs bind to eIF4E and prevent its interaction with eIF4G, 
disrupting the assembly of eIF4F and thereby cap-dependent initiation (Pause et al. 
1994, Gingras et al., 1999, 2001, Marcotrigiano et al., 1999, Pause et al., 1994). 
However, upon activation of the mammalian Target of Rapamycin (mTOR) by growth 
factors, mitogens and/or cytokines stimulations, 4E-BPs are phosphorylated at 
serine/threonine residues leading to eIF4E release and stimulation of eIF4F complex 
formation, and thus translation (Figure 1-7).  
 mTOR is a Serine/Threonine kinase in the PI3K/Akt signalling pathway and is 
activated by signals from extracellular stimuli, amino acid presence, and energy status 
of the cell. Upon activation, the mTOR Complex 1 (mTORC1) phosphorylates residues 
corresponding to Thr37 and Thr46 on human 4E-BP1, which will activate the 
phosphorylation of Thr70 and Ser65 in a sequential manner (Gingras et al., 1999a, 
2001). In addition, other kinases such as Akt have been proposed to induce 4EBP1 
phosphorylation on Thr70 and Ser65 (Beugnet et al., 2003). 
 
Chapter 1                                                                                                    Introduction 
 
52 
 
  
 
 
Figure 1-7 Regulation of eIF4Fcomplex formation. 
(A) Upon phosphorylation of the translational repressor 4E-BP1 by the cellular kinase 
mTOR, 4E-BP1 is released from eIF4E allowing the recruitment of eIF4G and eIF4F 
complex assembly. (B) eIF4E binds 7-methyl guanine cap of the mRNA, recruits 
eIF4G and eIF4A to facilitate eIF4F assembly (adapted from Mohr, 2005). 
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Eukaryotic initiation factor 4E-binding protein 1 (4EBP1) is a well-known 
downstream target of the Mammalian rapamycin complex 1 (mTORC1). Previous 
studies have identified two regulatory motifs in the 4EBP1;  the short sequences that 
interact with the mTORC1 component raptor called TOR signalling motifs at the C 
terminus, and a RAIP motif (named after its sequence - Arg-Ala-Ile-Pro) in the N 
terminus. The TOR signalling (TOS) motif mediates the interaction of mTOR/Raptor 
with 4EBP1. This leads to its phosphorylation at Thr37/46, which is followed by the 
phosphorylation of Thr70 residue. In 1999, Gingras et al. demonstrated that the 
phosphorylation of 4EBP1 on Thr37 and Thr46 alters the conformation of the 4E-BP1-
eIF4E complex to allow access of different kinases to the other phosphorylation sites 
on 4E-BP1. However Mothe-Satney et al., 2000 showed that 4EBP1 phosphorylation 
of Thr70 is independent of prior phosphorylation of Thr37 and Thr46. Most studies 
have suggested that the phosphorylation of 4EBP1 on Thr70 is the critical step to 
induce the release of eIF4E from 4E-BP1 (Schalm & Blenis 2002, Nojima et al. 2003, 
Equchi et al., 2006) (Figure 1-7A). In addition, the phosphorylation of 4EBP1 on Ser65 
alone is insufficient to mediate the release of 4E-BP1 from eIF4E, and occurs 
subsequently to Thr 70 residue phosphorylation (Equchi et al., 2006). 
 
1.2.2.3 REGULATION OF eIF4E PHOSPHORYLATION 
The activity of eIF4E is also regulated by the phosphorylation of the residue 
Ser209. The crystal structure of mammalian eIF4E suggested that its phosphorylation 
increases the affinity to the mRNA cap structure through the formation of a salt bridge 
that stabilizes mRNA–eIF4E interaction (Minich et al., 1994, Marcotrigiano et al., 
1997). However, more recent studies demonstrated that phosphorylated eIF4E 
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displays a reduced affinity (2–4-fold) for the cap (Scheper et al., 2002, Zuberek et al., 
2003). 
 The phosphorylation of eIF4E on Ser209 is mediated by the eIF4G-associated 
kinase, MNK1 and MNK2, through the activation of the Mitogen Activated Protein 
Kinase (MAPK) pathway as detailed in the next section. Unlike MNK2, which induces 
basal and constitutive eIF4E phosphorylation, MNK1 activation, induced by MAPK 
effectors, is responsible of eIF4E phosphorylation. The role of eIF4E in tumorigenesis 
is well established and the overexpression or phosphorylation of eIF4E leads to 
malignant transformation by promoting the translation of mRNA involved in cell 
proliferation and apoptosis inhibition therefore, it constitutes a prominent target for 
cancer therapy (Siddiqui et al., 2015, Musa et al., 2016, Bramham et al., 2016). In 
addition, eIF4E phosphorylation regulates cellular translation during microbial infection 
and has an important impact on microbial pathogenesis (Piciriollo et al., 2014).  
 
1.2.2.4 REGULATION OF eIF4E ACTIVITY AND MAPK SIGNALLING 
PATHWAYS 
Cellular signaling pathways regulate and induce changes in mRNA translation 
by modulating the phosphorylation status and the activity of the translational 
machinery components in response to various stimuli, including infection. Mitogen 
activated-protein kinases (MAPKs) are a group of Ser/Thr kinases. In mammals, 14 
MAPKs have been characterized, but the most extensively studied groups are the 
ERK1/2, JNKs, and p38 isoforms. Their activity is mediated through a family of Ser/Thr 
kinases termed MAPK-activated protein kinase (MAPKAPK). Two MAPKAPKs that 
have been directly implicated in the regulation of translation are the RSKs and the 
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MAPK-interacting kinases (MNKs). RSK isoforms are regulated by ERK1/2, acting 
downstream from growth factors and mitogens. MNKs are activated by either ERK1/2 
or p38, downstream from both mitogens and stress inducing stimuli such as infection 
(reviewed by Cargnello and Roux, 2012). 
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Figure 1-8 Mitogen activated protien kinases signalling pathway. 
The Ras/Raf/ERK pathway culminates in the activation of the MNKs (especially Mnk1). 
Mnk1can also be activated by p38 MAPK downstream of cytokines or stressful stimuli. 
Both Mnk1 and Mnk2 specifically phosphorylate eIF4E at Ser209. 
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The activity of eIF4E is regulated by MNK1 and MNK2, which phosphorylate a 
serine residue (Ser209 in human eIF4E) (Fukunaga and Hunter 1997, Waskiewicz et 
al., 1997). MNK1/2 exists in two isoforms named MNK1a and b, and MNK2a and b, 
respectively. Both MNK1a and MNK2a have long C-termini domain implicated in their 
predominant cytoplasmic localization. In contrast, MNK1b and MNK2b, contain short 
carboxyl termini domain resulting in an equal distribution between the nucleus and 
cytoplasm. In most cell lines, the basal activity of MNK2a is high, which is thought to 
be a consequence of its ability to constitutively associate with activated ERK. 
Conversely, MNK1a has a low basal activity and it is activated by ERK and p38 MAPK 
in response to stimuli such as growth factors and phorbol esters or cytokines and 
environmental stress (Scheper et al., 2001). Likewise, MNK1b exhibits high basal 
activity, whereas MNK2b, which is the only MNK variant that lacks the MAPK-binding 
domain, has a very low basal activity (reviewed by Buxade et al., 2008, Roux and 
Topisirovic, 2012) (Figure 1-8). 
It has been reported that MNKs are recruited to eIF4E through association with 
the carboxy-terminal part of eIF4G (Pyronnet et al., 1999). As a consequence, Mnk1 
only phosphorylates eIF4E when bound to eIF4G and this phosphorylation occurs 
within a tri-partite complex of Mnk1-eIF4G-eIF4E (Shveygert et al., 2010). Therefore, 
the phosphorylation of eIF4E occurs during or shortly after the assembly of the eIF4F 
complex on the 5′-mRNA cap. Moreover, the eIF4E phosphorylation site on Ser209 is 
located in the proximity of the entrance of the cap-binding pocket of eIF4E. Therefore, 
it has proposed that the phosphorylation status of eIF4E alters its cap-binding activity 
(Topisirovic et al., 2011). Previous studies initially predicted that a salt bridge between 
the phosphate group of Ser209 and Lys159, forms a “clamp” that stabilizes the eIF4E-
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5′ cap structure complex (Marcotrigiano et al., 1997, Matsuo et al., 1997). However, 
subsequent studies revealed that the phosphorylation of eIF4E reduces its affinity for 
the cap (Scheper et al., 2002, Slepenkov et al., 2006).  
In addition, other studies have suggested that eIF4E phosphorylation was 
shown to correlate with increased global cellular translation (Kaspar et al., 1990; 
Manzella et al. 1991; Walsh and Mohr 2004; Worch et al., 2004) or decreased global 
translation rates (Knauf et al., 2001; Morley and Naegele 2002; Naegele and Morley 
2004). Though, eIF4E phosphorylation seems to have a variable effects on cell global 
translation depending on the different experimental condition (reviewed by Roux & 
Topisirovic, 2012). 
More recent studies have demonstrated that the phosphorylation of eIF4E can 
selectively regulate the translation of specific mRNA subsets, such as anti-apoptotic 
Mcl-1 (Wendel et al., 2007), inflammation factors (e.g., Ccl2 and Ccl7) and tumor 
progression factors (e.g., MMP3 and MMP9) (Furic et al., 2010). These findings 
suggest an interesting possibility that phosphorylated eIF4E modulates the 
inflammatory response and stimulates tumorigenesis by selectively up-regulating 
translation of mRNAs that encode proteins critical for these processes (reviewed by 
Roux and Topisirovic, 2012). 
Recent data also indicate that the MNKs play a key role in the production of the 
inflammatory cytokine TNFα. The post-transcriptional control of TNFα synthesis is 
largely mediated through AREs in the 3′-UTR of its mRNA. Several ARE-BPs may be 
Mnk substrates, including hnRNP A1, phosphorylation of hnRNP A1 by Mnks 
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decreases its ability to bind the TNFα mRNA AREs therefore induces TNFα (Buxade 
et al., 2005, Proud, 2007). 
 
1.2.3  TRANSLATION INITIATION AND INFECTION 
 
1.2.3.1 CONTROL OF eIF2 DURING INFECTION 
Host translation initiation can be impaired by four cellular kinases that 
phosphorylate eIF2α on Ser51, each of which is triggered by a distinct environmental 
or metabolic stress. Phosphorylated form of eIF2α exhibits greater affinity for the 
recycling factor eIF2B and inhibits its guanine nucleotide exchange factor (GEF) 
activity. Since eIF2B is limiting, small changes in phosphorylated eIF2α concentration 
have dramatic effects on translation initiation (Hinnebusch and Lorsch, 2012). Viruses 
have developed strategies to prevent accumulation of phosphorylated eIF2, by 
antagonizing PKR, either via virus-encoded dsRNA decoy molecules, dsRNA-binding 
proteins, or PKR-binding proteins, each of which prevent PKR activation, or via 
induction of cellular PKR antagonists. This represents a major strategy used by viruses 
to resist the antiviral effects of interferon (IFN) (Walsh & Mohr, 2011). Recently, eIF2α 
phosphorylation has been reported after infection with intracellular bacteria such as, 
Listeria monocytogenes, Chlamydia trachomatis, or Yersinia pseudotuberculosis 
(Shrestha et al., 2012). Cells unable to phosphorylate eIF2α were more susceptible to 
bacterial invasion, suggesting a role for eIF2α phosphorylation in activating NFκB and 
pro-inflammatory cytokine production. 
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In fact, persistent chronic pathogen infection induces endoplasmic reticulum 
(ER) stress due to cellular exposure to pro-inflammatory cytokine and antimicrobial 
protein production, stimulated by LPS, a PAMP produced by gram-negative bacteria 
that activates TLR4 signaling (Woo et al., 2009). PERK, which is activated by ER 
stress, phosphorylates eIF2α. This suppresses global translation but promotes the 
translation of a subset of cellular mRNAs harboring upstream ORFs (uORFs). One 
such uORF-containing mRNA encodes the transcription factor ATF4, which in turn 
induces the transcription factors ATF-3 and CHOP (C/EBP homologous protein). 
Sustained CHOP production is harmful and induces apoptosis. Similarly, the activation 
of ER stress pathways may also be important for Mycobacterium tuberculosis survival 
in macrophages (Seimon et al., 2010, Lim et al., 2011). 
 
1.2.3.2 CONTROL OF IMMUNE EFFECTORS BY eIF4E 
In addition to the role of eIF2 in host defense and control translation, the 
production of cellular innate immune effectors is subject to translation control. Notably, 
eIF4F and its regulators control the translation of mRNAs encoding innate immune 
effectors through multiple, independent, signalling pathways, which probably act 
synergistically to regulate different components of the host innate response. mTOR 
signaling, which in addition to regulating translation in response to metabolic status 
and physiological stress, also controls type I IFN production. Dendritic cells derived 
from 4E-BP1/2-deficient mice produce more IFN in response to infection. Indeed, the 
upregulation of IRF-7 (interferon regulatory factor-7), a transcription factor, mRNA 
translation in 4E-BP1/2-deficient MEFs, leads to a higher basal type I IFN production 
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(Colina et al., 2008). Furthermore, the inhibition of mTORC1 by rapamycin induces 
autophagic cell death and reduces bacterial burden during M. tuberculosis infection 
(Zullo et al., 2014, Dong et al., 2016). 
The phosphorylation of the cap-binding protein eIF4E on S209 by the eIF4G-
associated kinase Mnk1 independently controls translation of the mRNA encoding the 
NFκB inhibitor IκBα (Herdy et al., 2012). Altered eIF4E activity, via the mitogen-
activated protein kinase (MAPK)-MNK1-MNK2-eIF4E pathway, can thus limit or 
promote translation of host mRNAs encoding the effector proteins that mediate innate 
responses. A previous study has provided mechanistic insights into the role of the 
phosphorylation of eIF4E. Using mouse embryonic fibroblasts (MEFs) derived from 
mice expressing wild type or S209A eIF4E, a non phosphorylatable form, the authors 
showed that preventing eIF4E phosphorylation resulted in a lower translation of IκBα 
mRNA. Given that IκBα binds and sequesters NFκB in the cytoplasm, this leads to 
inhibition of the transcriptional activity of NFκB. The lowered level of IκBα mRNA 
translation correlated with increased NFκB transcription, which promotes the 
production of interferon-β (IFN-β) (Herdy et al., 2012). Therefore this suggested that 
eIF4E phosphorylation is important for the innate immune response. The authors went 
on to show that viral replication was promoted in cells deficient in eIF4E 
phosphorylation.  
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1.2.3.3 CONTROL OF TRANSLATION THROUGH STRESS GRANULES 
ACCUMULATION DURING INFECTIONS 
Stress granules formation is detected during viral infection when translation 
initiation is impaired, and eIF2α phosphorylation induced, leading to accumulation of 
non-translating mRNAs, mRNA binding proteins (PABP, TIA-1, TIAR, and G3BP), 40S 
ribosome subunits and a subset of initiation factors including eIF4E, eIF4G, eIF4A and 
eIF3 inside stress granules (Decker and Parker, 2012). Likewise, bacterial infection 
can induce SG formation, as amino acid depletion, GCN2 activation, and eIF2α 
phosphorylation triggered by Shigella or Salmonella results in TIA-1-containing 
cytoplasmic SGs (Tattoli et al., 2012). Interestingly, the manipulation of SG dynamics 
by the opposing actions of PKR and the protein phosphatase 1 acting on eIF2 
phosphorylation/dephosphorylation balance may prevent sustained translational 
repression and be a conserved response to viral infection that can be exploited for 
pathogen persistence (Ruggieri et al., 2012). 
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1.2.4 PROJECT AIM & OBJECTIVES 
Tuberculosis kills more than 1.5 million people each year, and one third of the 
population carry a latent M. tuberculosis infection. There is still an urgent need to 
improve the treatment strategies of the disease as well as improving the effectiveness 
of the current treatments by developing adjunctive therapies that target the host 
response to the disease. The development of host directed therapies will be expedited 
by further understanding of how this pathogen hijacks host cell processes to facilitate 
survival. Key to this process is the regulation of host gene expression. Indeed, the 
hallmark of post-transcriptional regulatory mechanisms, which include the translation 
of mRNA, is the induction of acute changes in the proteome, which must adapt to rapid 
changes in the cell environment. 
To date very little is known about the translational control exerted by bacterial 
pathogens, including M. tuberculosis and how this contributes to pathogenesis. 
Therefore, the hypothesis is that mycobacteria regulate the host response by affecting 
the translational machinery. The following objectives will test this hypothesis, using M. 
bovis BCG as a surrogate for M. tuberculosis; 
 Study the effect M. bovis BCG (Bacillus Calmette–Guérin) infection on 
macrophage mRNA translation initiation by; 
 Investigate the effect of M. bovis BCG infection on eIF2α in murine 
macrophage. 
 Measure the global translation level of M. bovis BCG infected macrophages 
using polysome profiling. 
 Investigate the effect of M. bovis BCG infection on eIF4E and-4EBP1 in 
murine macrophage. 
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 Investigate the effect of phagocytosis and TLR stimulation on eIF4E in 
murine macrophage. 
 Study the regulation of eIF4E phosphorylation in M. bovis BCG infected murine 
macrophages by; 
 Investigating the effect of M. bovis BCG infection on MNK activity and thus 
eIF4E phosphorylation on survival of M. bovis BCG in murine 
macrophages. 
 Study the importance of ERK and p38 activity in M. bovis BCG-infected 
murine macrophages. Specifically this included investigation of the: 
 Activity of ERK and p38 kinases in M. bovis BCG -infected murine 
macrophages. 
 Impact of ERK and p38 inhibition on eIF4E phosphorylation and M. 
BOVIS BCG replication in infected cells 
 Study the Role of ERK, MNK, eIF4E phosphorylation on mycobacterial infection 
pathogenesis by; 
 Investigating the effect of inhibiting eIF4E phosphorylation on TNFα and IL-
10 production in RAW264.7 macrophages during M. bovis BCG infection. 
 Investigating the effect of inhibiting eIF4E phosphorylation on 
mycobacterial phagosomal acidification in RAW264.7 macrophages. 
 Investigating the effect of the inhibition of ERK on the induction of 
autophagy marker (LC3) in RAW264.7 macrophages during M. bovis BCG 
infection. 
 Investigating the effect of the inhibition of ERK on caspase-3/-7 activation 
in RAW264.7 macrophages during M. bovis BCG infection. 
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2. MATERIALS AND METHODS 
 
2.1. BACTERIAL CULTURE AND GROWTH CONDITIONS  
2.1.1. GROWTH OF M. BOVIS BCG ON 7H11 AGAR MEDIA 
M. bovis BCG Pasteur, which was originally purchased from the American Type 
Culture Collection (ATCC), was inoculated using sterile loop on a Middlebrook 7H11 
agar (Difco, Becton Dickenson) plates, supplemented with 5% Oleic acid-albumin-
dextrose-catalase (OADC) enrichment. The culture was incubated in a static incubator 
at 37ºC (LTE, Laboratory Thermal Equipment LTD) for 17 to 21 days. 
2.1.2. GROWTH OF M. BOVIS BCG IN 7H9 BROTH 
Middlebrook 7H9 broth (Difco, Becton Dickenson), supplemented with 0.05% 
Tween80 and 10% albumin-dextrose catalase (Sigma-Aldrich) v/v, was inoculated 
with a bacterial colony from a solid media in a universal tube (Sterilin UK), and then 
incubated in shaking incubator (innova4000, New Brunswick Scientific) at 37ºC for 5 
to 7 days. 
2.1.3. BACTERIAL CRYOPRESERVATION  
Bacterial stocks were maintained and stored in -80C freezer, when M. bovis BCG 
culture broth reached a density of 108 cell/ml. 20% (v/v) glycerol solution was used 
and mixed with an equal volume of bacterial suspension, then stored in 1ml Cryovials. 
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2.2. CELL CULTURE METHODS 
2.2.1. GROWTH AND MAINTENANCE OF CELL LINES 
2.2.1.1. MOUSE LEUKEMIC MONOCYTE-MACROPHAGE CELLS (RAW 
264.7) 
RAW 264.7 cells, were originally purchased from European Culture Collections 
Organization, are a macrophage-like, Abelson leukemia virus transformed, cell line 
derived from BALB/c mice. RAW 264.7 cells were grown in Dulbecco`s Modified Eagle 
Medium (DMEM) (Gibco®,Life Technology) containing 25mM glucose, 1mM Sodium 
Pyruvate, 4mM L-Glutamine, and supplemented with 10% (v/v) Foetal Bovine Serum 
(FBS). The cells were cultured in a vented (75cm2) flask (Thermo Fisher Scientific Inc.) 
containing 15ml of fresh media, and incubated at 37ºC in 5% CO2 incubator (Galaxy 
S; Wolf Laboratories Ltd). When cells were reached 80-90% confluency, washed with 
PBS, and then harvested by gently scrapping and centrifuged at 1000Xg for 3 minutes. 
The pellet was re-suspended in 5ml fresh DMEM media, for counting and seeding in 
to different dishes. 
2.2.1.2. CRYOPRESERVATION OF CELL LINES  
To make a frozen stock, cells were pelleted through centrifugation at 1000xg for 3 
minutes. The supernatant was removed and the cell pellet was resuspended in 2ml of 
freezing media (table 2-1) per 75cm2 flask. 0.5 ml aliquots were transferred into sterile 
cryovials. These vials were wrapped inside cotton wool in a polystyrene box, which 
was placed in a -80C freezer, allowing the cells to freeze slowly overnight. The next 
day the vials were transferred into liquid nitrogen for long term storage. 
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Table 2-1 Macrophage cell lines 
 
Cell Line 
 
Culture 
Properties 
 
Tissue/ 
Origin 
 
Cell 
 Type 
 
Freezing  
Media 
 
Complete 
Growth 
Medium 
 
RAW 
264.7 cells 
 
Adherent 
 
Abelson 
leukemia 
virus induced 
tumor 
Mouse 
 
Macrophage 
 
DMEM, 10% 
foetal calf 
serum (FCS), 
10% 
dimethylsulpho
xide (DMSO) 
 
DMEM, 10% 
foetal calf 
serum 
(FCS), 
 
2.2.2. RECOVERY OF CRYOPRESERVED CELL 
To resuscitate frozen cells from liquid nitrogen storage, cells were thawed rapidly in a 
37C water bath and transferred to 5ml of warm appropriate media in sterile centrifuge 
tube, then centrifuged at low speed 1000xg for 3 min. The pellet was resuspended in 
7ml appropriate complete media and seeded in 15cm2 vented flask. 
2.2.3. CELL COUNTING USING HAEMOCYTOMETER    
Cell concentration was calculated using a haemocytometer (Weber Scientific 
International Ltd), by pipetting a small volume of cell suspension under the 
haemocytometer coverslip on each side, and counting in 4 small squares on each side 
under the microscope. The average of the 4 small squares between each side was 
multiplied by 4 (equal number of cells in one large square), then multiplied by 5x103 
(equal number of cells per ml).  
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To dilute the cell suspension to the concentration required (eg; 5x105) the following 
equation was used  
 
    Concentration required X volume required     =  
                Calculated concentration 
 
 
2.3. INFECTION OF CELL MONOLAYERS WITH M. BOVIS BCG 
2.3.1. CELL MONOLAYER PREPARATION 
For adherent cells, RAW 264.7 cells were seeded in different dishes (Thermo Fisher 
Scientific Inc.) at a required density per well a day before starting the infection and/or 
treatment. To grow RAW264.7 cells on a coverslip, the coverslip was dipped into 70% 
ethanol (v/v), placed in a 24 well plate and then washed by adding sterile tissue culture 
grade water. Cells were seeded in to the well at 2.5-3. 0 x 105 cells per well.  
2.3.2. BACTERIAL PREPARATION AND INFECTION OF MONOLAYERS 
Using aseptic technique, M. bovis BCG cultures were checked for contamination using 
a Brain Heart Infusion (BHI) plate (Fluka, Sigma-Aldrich). The subsequent day, the 
culture was transferred to Eppendorf tube and centrifuged at 14,000 rpm for 5 min, 
and washed 3 times with PBS. Optical density (OD) at 600nm was measured using a 
spectrophotometer (WPA, Biotech Photometer), and Colony Forming Units (CFU) was 
calculated based on the equation;  
OD (600) of 1 = 1X108 cfu/ml 
Then the M. bovis BCG suspension was diluted with the culture media to the required 
multiplicity of infection (MOI). The following equation was used; 
 
Concentration required X volume required    =    volume in ml of M. bovis BCG suspension 
                         Calculated concentration 
 
Volume in ml was taken from cell 
suspension 
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To prepare heat-killed M. bovis BCG, bacteria were killed by heating 1ml M. bovis 
BCG suspension in Thermostat Plus (Eppendorf) to 80 ºC for 15 minutes. 
In a class ǁ bacteriology cabinet, the cell culture medium was aspirated from each dish 
and replaced with M. bovis BCG suspension, then the cells were incubated at 37ºC in 
5% CO2 incubator (New Brunswick Scientific). Three hours later, cells were washed 
twice with PBS (2ml per well) to remove extracellular bacteria and harvested. For later 
time points, fresh media was added at 3hpi and the cells were incubated again at 37ºC 
in 5% CO2 to be harvested at 18h post infection or 24h post infection. 
 
2.3.3. BACTERIAL LABELLING FOR MICROSCOPY 
M. bovis BCG was grown to mid log phase in 7H9 media and checked for 
contamination using Brain Heart Infusion (BHI) plate (Fluka, Sigma-Aldrich). The 
subsequent day, the culture was transferred to Eppendorf tube and centrifuged at 
14,000xg for 5 min, the supernatant was removed. The pellet was resuspended in 
carbonate buffer (1 capsule dissolved in 100ml sterile water to yield 0.05 M carbonate-
bicarbonate buffer, pH 9.6)  containing 100mg/ml FITC dye, then incubated at 37 ºC 
for 30 minutes with shaking. Thereafter, the FITC labelled M. bovis BCG was 
centrifuged, washed and the OD measured (as mentioned above) to be ready for 
confocal microscopy experiments. 
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2.4. TREATMENT OF CELL CULTURE MONOLAYER WITH KINASE 
INHIBITORS 
Kinase inhibitors (see table 2-2), were made up to 5-10mM stock solutions with DMSO, 
and stored at -80ºC as aliquots. Prior to use, an aliquot was thawed and diluted in 
DMEM to the desired concentration and added to cells. 
 
Table 2-2 Kinase inhibitors used in this study. 
 
Name 
 
 
Targets 
 
Solubility 
 
Working 
Concentration 
 
Supplier 
SCH772984 ERK1,2 In DMSO 10-20µM Selleck- chemical 
CGP 57380 MNK1 In DMSO 10-20µM Tocris 
SB 203580 P38 In DMSO 10-20µM Tocris 
 
 
2.5. TREATMENT OF CELL CULTURE MONOLAYER WITH TLR AGONISTS. 
RAW264.7 cells were stimulated by the TLR4 agonist LPS (Sigma-Aldrich) at 
concentration 0.1µg/ml for the time indicted in each experiment. PAM3CYS 
(InvivoGen) is a TLR2 agonist and was used at a concentration 1µg/ml for the time 
indicted in each experiment. 
 
2.6. CELL LYSIS.  
2.6.1. RIPA LYSIS BUFFER 
Cells were harvested using 1ml complete RIPA (Radio-immuno-precipitation Assay) 
buffer (Santa Cruz Biotechnology, Inc) per 2x107 cells. Complete RIPA buffer was 
supplemented before use with 4mM of phenylmethylsulfonyl fluoride (PMSF) solution 
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(a protease inhibitor), 2mM sodium orthovanadate solution (a phosphatase inhibitor) 
and 10μl protease inhibitor cocktail solution per ml of 1X RIPA Lysis buffer. The cells 
were scraped, transferred into eppendorf tubes, and left on ice for half an hour, then 
centrifuged at the maximum speed of 14,000 rpm for 20 min at 4ºC (eppendorf, 
Centrifuge 5415 C). The resulting protein lysates were stored at -20ºC.  
2.6.2. OTHER CELL LYSIS BUFFERS 
Occasionally, other lysis buffers were used in some specific experiments, provided by 
manufacturers within kits; Array lysis buffer was used with the Proteome Profiler 
Human Phospho-Kinase Array Kit (R&D systems), Caspase-3-7 lysis buffer was used 
with Apo-ONE® Homogeneous Caspase-3/7 Assay kit (Promega). 
 
 
2.7. BICINCHONINIC ACID (BCA) PROTEIN CONCENTRATION ASSAY 
The total protein concentration of each cell lysate samples was determined by BCA 
assay, using a kit and following the manufacturer`s instructions (Pierce™, Thermo 
Fisher Scientific Inc.).   
This method relies on two reactions; reduction of Cu+2 to Cu+1 by the peptide bonds in 
protein, the amount of Cu+1 is proportional to the amount of protein present in the 
sample. The chelation of two molecules of bicinchoninic acid (BCA) with one cuprous, 
result in the formation a purple-colored product that strongly absorbs light at wave 
length 562nm, increasing in a linear manner with increasing protein concentration, 
over a broad working range (20-2000μg/mL).   
 A series of dilutions of known concentration were prepared from the standard protein 
(Bovine serum albumin BSA), and assayed alongside the unknown samples by 
measuring the absorption spectra of both standards and unknowns with 
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spectrophotometer (WPA, Biotech Photometer) after 30 min incubation at 37ºC. Then 
the concentration of each unknown was determined from the standard curve, which 
was prepared by plotting the average Blank-corrected 562nm measurement for each 
BSA standard vs. its concentration in μg/mL. 
 
2.8. IMMUNOBLOTTING 
2.8.1. SAMPLE PREPARATION 
Protein samples were prepared by adding one volume of 3X SDS Red Loading Buffer 
(New England BioLabs Inc.), composed from 62.5 mM Tris-HCl, 2% (w/v) SDS, 10% 
glycerol and 0.01% (w/v) phenol red, to 1/10 volume 30X Reducing Agent DTT (New 
England BioLabs Inc.) and mixing with cell lysates containing a known amount of 
protein, usually 40µg. The purpose of these reagents is to confer a negative charge 
and disrupt the tertiary structure and quaternary structure of proteins. Each protein 
sample was heated for 3 minutes at 100ºC, to denature them then cooled to room 
temperature before it was loaded onto a gel. 
 
2.8.2. GEL ELECTROPHORESIS  
Sodium dodecylsulfate polyacrylamide gel electrophoresis (SDS-PAGE) was used to 
separate proteins based on their molecular size. SDS-PAGE gels (Pierce™, Fisher 
Scientific Inc.) are ready-to-use, precast gels with varying concentrations of 
acrylamide to achieve larger or smaller pore size depending on degree of protein 
separation required. 4-20% or 10% SDS-PAGE gels were used in in this thesis and 
loaded with protein samples (40µg) prepared previously and Prestained Protein 
Marker (P7708, New England BioLabs Inc.) with a molecular weight broad range 
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between 175kDa and 7kDa. The gel was run at 100-120V in a running buffer (1X: 25 
mM Tris, 192 mM glycine, 0.1% SDS), until the dye reached the bottom of the gel. 
2.8.3. WESTERN BLOT  
The proteins were transferred from the gel onto Protran™ BA83 nitrocellulose (NC) 
membrane (WhatmanTM, GE healthcare life science), by preparing a sandwich (filter 
paper- gel- nitrocellulose membrane- filter paper). The sandwich was then clamped 
between two sponges which were themselves stabilized between two plastic scaffolds 
submerged in transfer buffer (1X: 25 mM Tris, 192 mM glycine, 200ml methanol). 
To transfer the proteins, electrical current at 90V was applied for one hour in the 
presence of an ice pack and magnetic stirrer. Subsequently, the membrane was 
blocked in 5% non-fat dry milk (Marvel) or 5% Bovine Serum Albumin (BSA) (Sigma-
Aldrich) in 1x TBS for one hour at room temperature to prevent non-specific binding of 
antibodies, then washed with TBS-T. The blocked membrane was probed with a 
primary antibody (table 2-4) at 4ºC overnight, while rocking. Thereafter, the membrane 
was washed twice for 30sec and twice for 10min while rocking with TBS-T, and then 
membranes were incubated with appropriate Horse-Radish Peroxidase-Conjugated 
secondary antibodies (Dako), for one hour at room temperature (table4). 
After washing the membrane twice for 30sec and twice for 10min, a chemiluminescent 
substrate, Super Signal West Pico Chemiluminescent Substrate (Pierce™, Thermo 
Fisher Scientific Inc.) or ECL blotting substrates (Clarity™, BIO RAD), was used 
following manufacturers’ guidelines. Equal volumes of chemiluminescent reagents 
were mixed and placed on the membranes for five minutes, then removed and the 
membranes were enclosed in cellophane. The light signal was detected either by X-
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ray film superRX (FUJIFILM Corporation) or digital imaging (FluorchemQ, Alpha 
Innotech).  
Stripping of the membrane for repeated probing was carried out with the Restore 
Western Blot Stripping Buffer (Pierce™, Thermo Fisher Scientific Inc.) as per 
manufacturers instruction. 
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Table 2-3 Western blot solutions 
 
Solutions 
 
Composition 
 
10x TBS-Tween 
 
24.2g Tris-Base, 80g Sodium Chloride 
0.05%Tween-20, in 1L Milli-Q® Water  
 pH to 7.6  
 
Blocking Solution 
 
5% Bovine Serum Albumin or 5% non-fat 
dried milk (w/v) in TBS-Tween  
 
Running Buffer 
 
3.0g Tris-Base, 14.4g Glycine, 5.0ml 
20% SDS Milli-Q® Water up to 1L 
 
 
Transfer Buffer 
 
3.0g Tris-Base,14.4g Glycine, 200ml 
Methanol, 800ml Milli-Q® Water 
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Table 2-4 Summary of the Primary and secondary Antibodies Dilutions 
 
Primary Antibodies 
 
Blocking 
Solution 
 
Solution/ Dilution 
 
Source 
 
Secondary 
Antibodies* 
 
Polyclonal-rabbit 
4EBP1 
 
5%Marvel in 
TBST 
1hr a RT 
 
5% BSA in TBS 
1:200 overnight at 4ºC 
 
SANTA CRUZ 
Biotechnology, INC 
sc-6936 
 
Anti-rabbit HRP 
1:2500 
 
Phospho-
4EBP1(Thr37/46) 
 
5%Marvel in 
TBST 
1hr a RT 
 
5% BSA in TBS 
1:1000 overnight at 4ºC 
 
Cell Signalling 
Technology 
#9459 
 
Anti-rabbit HRP 
1:2000 
 
Phospho-
4EBP1(Thr70) 
 
 
5% Marvel in 
TBST 
1hr a RT 
 
5% BSA in TBS 
1:1000 overnight at 4ºC 
 
Cell Signalling 
Technology 
#9455 
 
Anti-rabbit HRP 
1:2000 
 
Polyclonal-rabbit 
eIF4E 
 
5%Marvel in 
TBST 
1hr a RT 
 
5% Marvel in TBS  
1:2000 overnight at 4ºC 
 
Dr Simon Morley 
(University of 
Sussex)  
 
Anti-rabbit HRP 
1:2500 
 
Phospho-
eIF4E(Ser209) 
 
5%Marvel in 
TBST 
1hr a RT 
 
5% BSA in TBS 
1:1000 overnight at 4ºC 
 
Cell Signalling 
Technology 
#9741 
 
Anti-rabbit HRP 
1:2000 
 
Polyclonal-rabbit 
eIF2α 
 
5%Marvel in 
TBST 
1hr a RT 
 
5% BSA in TBS 
1:1000 overnight at 4ºC 
 
Cell Signalling 
Technology 
#9722 
 
Anti-rabbit HRP 
1:2000 
 
Phospho-
eIF2α(Ser51) 
 
5%Marvel in 
TBST 
1hr a RT 
 
5% BSA in TBS 
1:1000 overnight at 4ºC 
 
Cell Signalling 
Technology 
#9721 
 
Anti-rabbit HRP 
1:2000 
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Primary Antibodies 
 
Blocking 
Solution 
 
Solution/ Dilution 
 
Source 
 
Secondary 
Antibodies* 
 
GAPDH  
 
5%Marvel in 
TBST 
1hr a RT 
 
5% Marvel in TBS 
1:10000 overnight at 
4ºC 
 
Ambion®, Life 
Technologies Corp 
AM4300  
 
 
Anti-mouse 
HRP 
1:3000 
 
p42p44MAPK (ERK) 
 
5%Marvel in 
TBST 
1hr a RT 
 
5% BSA in TBS 
1:1000 overnight at 4ºC 
 
Cell Signalling 
Technology 
#9102 
 
Anti-rabbit HRP 
1:2000 
 
 
Phospho-
p42p44MAPK 
 
5%Marvel in 
TBST 
1hr a RT 
 
5% BSA in TBS 
1:1000 overnight at 4ºC 
 
Cell Signalling 
Technology 
#9101 
 
Anti-rabbit HRP 
1:2000 
 
MNK 
 
5%Marvel in 
TBST 
1hr a RT 
 
5% BSA in TBS 
1:1000 overnight at 4ºC 
 
Cell Signalling 
Technology 
#2195 
 
Anti-rabbit HRP 
1:2000 
 
Phospho-MNK 
 
5% BSA in 
TBST 
1hr a RT 
 
5% BSA in TBS 
1:1000 overnight at 4ºC 
 
Cell Signalling 
Technology 
#2111 
 
Anti-rabbit HRP 
1:2000 
 
ATF4 
 
5%Marvel in 
TBST 
1hr a RT 
 
5% BSA in TBS 
1:1000 overnight at 4ºC 
 
Cell Signalling 
Technology 
#11815 
 
Anti-rabbit HRP 
1:2000 
 
LC3B   
 
5%Marvel in 
TBST 
1hr a RT 
 
 
5% BSA in TBS 
1:1000 overnight at 4ºC 
 
Cell Signalling 
Technology 
#2775 
 
Anti-rabbit HRP 
1:2000 
 
* All secondary antibodies (Dako) diluted in 5% Marvel in TBS 
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2.9. PROTEOME PROFILER ARRAY 
In order to analyse the phosphorylation profiles for a wide range of protein kinases, 
the Human Phospho-Kinase Array (R&D Systems, Inc.) was used. The kit includes 43 
capture antibodies recognizing different phosphorylated sites on human kinases and 
two control proteins spotted in duplicate on nitrocellulose membranes. 
Lysates from RAW264.7 cells infected with M. bovis BCG for 18h or uninfected were 
diluted and incubated overnight with the Human Phospho-Kinase Array. After 24hr the 
array was washed to remove unbound proteins and incubated with a cocktail of 
biotinylated detection antibodies for one hour at room temperature, then washed. 
Streptavidin-Horseradish Peroxidase was added and incubated for 30 minutes. 
Finally, the membranes were washed 3 times and chemiluminescent detection 
reagents were added. The signal was detected in the same manner as in Western blot 
by X-ray film super RX (FUJIFILM Corporation), each captured spot representing the 
amount of phosphorylated protein bound. The average pixel density of duplicate spots 
were quantified using ImageJ software, and then the averaged background signal was 
subtracted from each spot. The raw results were then normalized for each individual 
protein by adjusting the uninfected signal to 100% and expressing the data as a 
percentage of the uninfected for each protein. 
 
2.10. INDUCTION OF APOPTOSIS BY CYCLOHEXIMIDE IN RAW264.7 CELLS 
To induce apoptosis with cycloheximide, an inhibitor of translational elongation, 
RAW264.7 cells were grown as in section 2.2 until they reached 80-90% confluence, 
then treated with 9µM cycloheximide diluted in DMEM, while the same volume of fresh 
media without cycloheximide was added to the uninfected-treated. The cells were 
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harvested after 20h, lysed as in section 2.5, and the protein concentration calculated 
as in section 2.6. 
 
2.11. INDUCTION OF eIF2 PHOSPHORYLATION BY DTT IN RAW264.7 CELLS 
DTT was used as a positive control for eIF2α phosphorylation (Christopher et al., 1992; 
Aarti et al., 2010). RAW 264.7cells were seeded in 6 well plates (Thermo Fisher 
Scientific Inc.) at 1 x 106 cells per well with 2ml DMEM supplemented with 10% FBS 
a day before treatment. When the cells reached 80% - 90% confluency, cells were 
treated with 2mM dithiothreitol (DTT) for 1hr, while medium was replaced in the control 
(uninfected-treated). Cells were harvested and lysed as in section 2.5 and protein 
concentration calculated as in section 2.6. 
 
2.12. INDUCTION OF AUTOPHAGY BY STARVATION IN RAW264.7 CELLS 
To induce autophagy, RAW264.7 cells were grown on sterile coverslips in 12- plates 
or 24-well (see section 2.3). The induction of autophagy was performed by substituting 
the growth media with nutrient free media, Earle’s balanced salt solution (EBSS) 
(Gibco®, Life Technology). Cells were incubated at 37C in 5% CO2 for 3hours, then 
cell lysis or immunostaining was carried out as described in section 2.11. 
 
2.13. CELL VIABILITY ASSAYS 
2.13.1. CRYSTAL VIOLET STAINING 
Crystal violet staining was used to quantify the number of attached cells, as an indirect 
measurement of cell death. Attached cells were stained with crystal violet, which binds 
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to proteins and DNA. Cells that have undergone cell death lose their adherence 
thereby reducing the amount of crystal violet staining in a culture.   
Cells were grown on 96-well plates and treated as indicated in each experiment. After 
the final wash, adherent cells were fixed with 4% formaldehyde and stained with 
crystal violet (0.5% Crystal violet (w/v), 20% Methanol (v/v), MilliQ water) for 20 
minutes at room temperature. Excess dye was removed by washing with distilled water 
and the dye absorbed by adherent cell nuclei was solubilized with methanol. 
Absorbance at 540nm was measured using a micro- plate reader. 
2.13.2.  CELL TITER GLO 
The CellTiter-GloR 2.0 Assay (Promega) provides a method to determine the number 
of viable cells in culture by quantitating the amount of ATP present, which indicates 
the presence of metabolically active cells.  
RAW264.7 cells were grown in white-walled 96-well plates then treated as indicated 
in each experiment. Then, the plate was taken out from the incubator to equilibrate the 
plate and its contents to room temperature for approximately 30 minutes. Equal 
volumes of the kit reagent and the medium per well were added (100µl), mixed for 2 
minutes to induce cell lysis and incubated for further 10 minutes to stabilize the 
luminescent signal, which was read by luminometer. 
  
2.14. COLONY-FORMING UNITS 
To assess intracellular M. bovis BCG survival, RAW264.7 macrophages seeded a day 
before were infected with M. bovis BCG at the indicated MOI. The culture supernatants 
were collected, and macrophages were lysed with 0.1% Triton X-100. Tenfold serial 
dilutions of supernatants and lysates were plated on Middlebrook agar plates (20µl) 
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which were incubated for 17-21 days at 37 ºC. The following equation was used to 
calculate the number of colony forming units (CFU) per ml; 
CFU per ml = Average number of colonies for a dilution x 50 x dilution factor.  
 
2.15. CASPASE -3/-7 ACTIVITY ASSAY 
2.15.1. LYSATE PREPARATION 
RAW264.7 cells were seeded in 6 wells plates the day before, then the cells were 
uninfected (media containing a vehicle) or infected at an MOI of 10, and treated with 
either the ERK inhibitor SCH772984 (5-20µM) or MNK inhibitor CGP57380 (20 µM). 
At each time point post infection, the medium containing floating cells was collected in 
a universal tube and the remaining cells were scraped and mixed with the medium. 
After centrifugation at 1000xg for 3 min, the supernatant was removed and the pellet 
washed 3 times with PBS. The pellet was resuspended in 50µl caspase-3-7 lysis buffer 
provided, and the cells were lysed by incubating on ice for 30 min. Later the lysed cells 
were centrifuged to pellet the cellular debris at 14,000 rpm at 4c, and the supernatants 
were collected and loaded into 96-well plate. 
2.15.2. CASPASE -3/-7 ASSAY 
After transferring 50 µl from each sample and control to the microplate wells, 50µl of 
caspase-3/-7 reaction buffer mixed with Z-DEVD-R110 substrate was added. 
Rhodamine 110 bis-(N-CBZ-L-aspartyl-L-glutamyl-L-valyl-L-aspartic acid amide) (Z-
DEVD-R110), is a non-fluorescent rhodamine 110-derived substrate containing DEVD 
peptides covalently linked to R110’s amino groups, after the cleavage by caspase-3/-
7, is converted first to the fluorescent monoamide and then to the even more 
fluorescent R110. R110 emits fluorescence at a wave length 520nm when it is excited 
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at 496nm, the fluorescence liberated was measured by a FLUOROSKAN ASCENT FL 
(Thermo-scientific) using 485nm excitation and 538nm emission filters.  
 
2.16. POLYSOME PROFILING EXPERIMENTS  
2.16.1. SUCROSE DENSITY GRADIENT CENTRIFUGATION  
Sucrose density gradient centrifugation enables the isolation of actively translating 
polysomal RNA through centrifuging cell lysates in a sucrose gradient at high 
centrifugal force. Components come to rest when their density is equivalent to that of 
the surrounding sucrose, allowing cellular components to be analysed according to 
density. 10X TMN buffer (3M NaCl, 150mM MgCl2, 150mM Tris-HCl at pH 7.5, 
10mg/ml heparin) was diluted 1 in 10 to produce 1X TMN buffer. 1X TMN buffer was 
then used to produce sucrose solutions at 10%, 18%, 26%, 34%, 42%, 50% and 60% 
sucrose in 20ml 1X TMN. To each of these, 1mg/ml cyclohexamide was added. 
Sucrose solutions were layered in ultracentrifuge tubes (Beckman Coulter Inc., Brea, 
CA, USA) at a volume of 1.6ml for each concentration by deposition and subsequent 
freezing of each layer at -80ºC, with the most dense layer (60% sucrose) at the bottom 
and the least dense (10%) at the top. Gradients were frozen at -20ºC overnight and 
thawed the morning before ultracentrifugation to allow layers to equilibrate. Upon 
thawing, 500μl of cytoplasmic cell lysates were added to the top of the thawed 
gradients and ultracentrifuged (150,000g, 2 hours, 4ºC).  
2.16.2.  POLYSOME PROFILING  
Polysome profiling is the spectrophotometric analysis of lysates ultracentrifuged 
through a sucrose gradient at 254nm, an absorbance wavelength of RNA. Peaks at 
higher densities are indicative of polysomes, which are strands of mRNA being 
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translated by multiple ribosomes. Peaks at lower densities are indicative of rRNA in 
singular 40S and 60S subunits, as well as free RNAs. Previously ultracentrifuged 
lysates were run through a density gradient fractionator (Teledyne ISCO, Lincoln, NE, 
USA), using 65% sucrose with 0.1% bromophenol blue as a dense chase solution 
(dispensed using a syringe pump (kd Scientific Inc.,Holliston, MA, USA)) to displace 
the gradient upwards. Absorbance was measured using PeakTrak software (Teledyne 
ISCO). 
 
2.17. IMMUNOFLUORESCENCE ASSAY  
2.17.1.  PLATING, FIXING AND PERMEABILIZING  
Cells were grown on glass microscope coverslips (Hendley-Essex) in 24-well plates. 
PBS was used to wash the cells prior to fixing in 4% (w/v) paraformaldehyde for 20 
minutes. Digitonin (50µg/ml) was used to permeabilize the cells for 5 minutes and then 
the excess digitonin was quenched by incubating the cells in quenching solution (50 
mM NH4Cl in PBS) for 5 minutes at room temperature. After washing with PBS twice, 
cells were blocked in 3% (w/v) blocking solution, which comprised of 3% bovine serum 
albumin (BSA) prepared in PBS, for 1 hour at room temperature. 
2.17.2.  IMMUNOFLUORESCENCE STAINING  
LC3 primary antibody was diluted in blocking solution as indicated in Table 2-5 and 
incubated with fixed cells overnight at 4˚C. The next day, the cells were washed three 
times in PBS before addition of the secondary antibody in blocking solution (see Table 
2-5), and incubated in the dark for 1 hour at room temperature. Slides were again 
washed three times and incubated with diamidino-2-phenylindole dye (DAPI) (Thermo 
Scientific™), diluted at concentration 1μg/ml in PBS for 1minute at room temperature. 
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After finish the washing step, the cells were mounted with antifade mounting medium 
(VECTASHIELD, VECTOR LABORATORIES) on microscopy glass slides (Thermo 
Scientific™). 
Table 2-5 Immunofluorescence antibodies 
 
Antibody 
 
Dilution 
 
Supplier 
Primary antibody 
LC3 
 
1:250  
In blocking solution* 
 
Cell signalling technology 
Secondary antibody 
Alexa Fluor 555 (red) 
Alexa Fluor 488 (green) 
Goat Anti-Mouse IgG 
 
5µg/ml in 
In blocking solution* 
 
Invitrogen™ 
Blocking solution; 3% (w/v) bovine serum albumin BSA in PBS 
2.17.3. LYSOTRACKER STAINING 
LysoTracker probes (LysoTracker®, Molecular probes by Life Technologies) are 
fluorescent acidotropic dyes used for tracking acidic compartments in living cells. 
These molecules accumulate in lysosomes and autophagosomes with an excitation 
577nm and emission 590nm. 
Cells were grown on glass microscope coverslips (Hendley-Essex) in 24-well plates 
then treated and infected as described in section 2.3. PBS was used to wash the cells, 
then pre-warmed medium containing the selected LysoTracker Red at the final 
concentration of 1µM is added. Staining was performed at 37°C, in 5% CO2 
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atmosphere, for an hour. Thereafter, cells are washed with PBS, cells are fixed and 
cover slips are mounted as described above. 
 
2.17.4. CELL IMAGING 
Cells were viewed by an A1+ confocal laser microscope (Nikon) using either the 40x 
or 60x oiled objective. Data analysis has been done with NIS-Elements AR software 
and images were taken over four fields, in triplicate. 
 
2.18. DETECTION OF TNF AND IL-10 PRODUCTION BY ELISA 
Cells were infected and/or stimulated as described in section 2.3 and the culture 
supernatants were collected and stored at -20 °C until analysis. This experiment was 
performed using ELISA Ready-SET-Go!® (eBioscience) kit, all solutions and 
antibodies were provided in the kit. The assay was performed according to 
manufacturer’s instructions.  
96–well ELISA plates were coated with capture antibodies; anti-mouse TNFα or anti-
mouse IL-10, then incubated at 4°C overnight. On the next day plates were washed 
with PBS/0.05% Tween 20 and blocked with 1X ELISA diluent provided and incubated 
at room temperature for 1h. Standard curves for TNFα (0-2000 pg/ml), IL-10 (0-1000 
pg/ml) were generated using mouse TNFα or IL-10. Later, 100µl from each standard 
and the samples were applied to the ELISA plates and incubated at 4°C overnight. On 
the next day plates were washed, both TNFα and IL-10,100 µl biotinylated anti-mouse 
detection antibodies provided for each cytokine were added, and incubated for a hour 
at room temperature. An Avidin-HRP secondary antibody was then used and 
incubated for 30 minutes. After the last washes, 100 µl of ELISA substrate TMB 
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(tetramethylbenzidine) was added, incubated for 2 minutes to detect TNFα and 
stopped the reaction. While with IL-10 detection plate was incubated for 10 -15 
minutes then the reaction was stopped. 
Using a plate reader the absorbance of each well at 450 nm is determined using ELISA 
plate reader (PerkinElmer, VICTOR3).  After making the fitting curve with the 
standards, the concentration of TNFα or IL-10 were calculated in each sample 
 
2.19. STATISTICAL ANALYSIS 
All experiments were done in triplicate and independently repeated at least three 
times, unless stated otherwise.  Data were analyzed by ANOVA and the results were 
expressed as mean ± SEM. Statistical significance was tested at p < 0.05 as critical 
value. For all analyses, Graph Pad software was used. 
 88 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter Three 
The effect of M. bovis BCG (Bacillus Calmette–Guérin) 
infection on macrophage mRNA translation initiation. 
 
 
 
 
 
 
 
 
Chapter 3                The effect of M. bovis BCG infection on translation initiation 
 
89 
 
3. THE EFFECT OF M. BOVIS BCG INFECTION ON TRANSLATION INITIATION. 
3.1. INTRODUCTION 
In response to pathogen invasion, eukaryotic cells have the ability to respond 
by modulating gene expression to activate the antimicrobial response. In addition to 
well-characterized transcriptional responses, the expression of many proteins involved 
in the innate and adaptive cell immune response is regulated at the level of translation 
(Piccirillo et al., 2014). Therefore to better understand the host response to M. bovis 
BCG infection, the regulation of protein synthesis and of the signalling pathways that 
control it were investigated. The impact of translational control on mycobacterial 
intracellular survival and host-pathogen interaction was also studied.  
To regulate translation, the activity of several eukaryotic initiation factors (eIFs) 
can be modulated to control the initiation of translation. eIF2α forms a ternary complex 
(TC) with GTP and the Met-tRNAMet and delivers the latter to the 40S ribosome in a 
process activated by the hydrolysis of GTP into GDP. Met-tRNAMet has a greater 
affinity for eIF2α-GTP than for eIF2α-GDP, which needs to be recycled to form a new 
TC. This reaction is catalysed by eIF2Bε of the heteropentameric complex (reviewed 
by Pestova et al., 2007, Jackson et al., 2010). During stress responses, eIF2α kinases 
phosphorylate eIF2α on Ser51, which prevents its binding to eIF2B, thereby blocking 
the recycling of eIF2-GDP. This in turn stalls translation initiation concomitantly with 
the up-regulation of translation of selected mRNA such as ATF4 (Activating 
transcription factor 4). There are four eIF2α kinases that are activated during cellular 
stress: PERK (PKR-like ER kinase), PKR (protein kinase double-stranded RNA-
dependent), GCN2 (general control non-derepressible-2) and HRI (heme-regulated 
inhibitor) (Wek et al., 2006).  
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eIF4E and 4E-BP1 also have key roles in the regulation of translation initiation. 
The eukaryotic translation initiation factor 4E (eIF4E) is a part of the eIF4F complex, it 
binds to the 5’ cap structure of cellular mRNA to initiate the recruitment of the 40S 
ribosomal subunit. The activity of eIF4E is regulated by two signalling pathways: the 
PI3K/Akt/mTOR pathway and the Ras/MAPK/MNK pathway. 4E-BPs (eIF4E-binding 
proteins) are downstream targets of the mTOR pathway involved in the control of 
eIF4E. mTOR phosphorylates 4EBPs to relieve eIF4E from 4EBPs allowing it to bind 
the mRNA (Raught & Gingras, 2007). The MAPK-interacting kinases (MNK1/2) 
phosphorylates eIF4E on Ser209 to stimulate translation of a specific subset of 
mRNAs. Many studies have revealed that phosphorylation of eIF4E selectively 
promotes translation of many mRNAs related to cell proliferation, host immunity and 
chemokine production (Pyronnet, 2000, Sonenberg & Hinnebusch, 2009, Piccirillo et 
al., 2014,). 
The aims of this chapter are to: 
1- Establish M. bovis BCG culture and infection model in macrophages. 
2- Investigate the effect of M. bovis BCG infection on eIF2α phosphorylation status 
in murine macrophage. 
3- Measure the effect of M. bovis BCG infection on the global translation level in 
murine macrophages using polysome profiling. 
4- Investigate whether M. bovis BCG infection induces 4EBP1 phosphorylation to 
enhance eIF4E availability in the cellular context. 
5- Investigate whether M. bovis BCG infection induces eIF4E phosphorylation in 
murine macrophages. 
6- Assess the role of phagocytosis and TLR stimulation on eIF4E phosphorylation. 
Chapter 3                The effect of M. bovis BCG infection on translation initiation 
 
91 
 
3.2. INTRACELLULAR BACTERIAL GROWTH AND MACROPHAGE 
ACTIVATION DURING MYCOBACTERIUM BOVIS BCG INFECTION. 
 
To determine the multiplicity of infection to be used in this project, the effect of 
the bacterial load on macrophage viability was assessed. The growth of M. bovis BCG 
culture has been discussed in the method section 2-1. Washed bacteria were used to 
infect murine macrophages RAW264.7 cells at a different multiplicity of infection 
(MOI). RAW264.7 macrophages were infected with M. bovis BCG for 24h at a 
multiplicity of infection 5, 10 or 20 bacilli per macrophage. As shown on (Figure 3-1A), 
an MOI of 5 or 10 had no significant effect on macrophage viability, while at a MOI of 
20 the number of viable macrophages was significantly reduced.  
Next, to measure intracellular M. bovis BCG survival, RAW264.7 cells were 
infected with M. bovis BCG at MOI of 5, 10 and 20 for 3, 24 and 48h then cell lysate 
was collected, and bacterial load was enumerated by plating on Middlebrook media 
and counting CFU after 17-21 days. While with infections at MOI of 5 and 10, M. bovis 
BCG grew and replicated, at MOI of 20 the number of bacteria declined. This 
correlated with the reduced number of viable macrophages (Figure 3-1B). Therefore 
for the subsequent experiments, an MOI of 10 was chosen, and heat-killed M. bovis 
BCG was used as a control to test whether the process was passive or require viable 
mycobacterium.  
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Figure 3-1 Intracellular growth and the effect of M. bovis BCG on RAW264.7 
macrophages. 
 
(A) RAW264.7 cells were infected with M. bovis BCG at 1:5, 1:10, and 1:20 ratios. At 
24hpi macrophages viability was checked using crystal violet staining, OD reading at 
540nm, results expressed as a percent of uninfected. (B) RAW264.7 cells were 
infected with M. bovis BCG at 1:5, 1:10 and 1:20 ratios at the time points shown, the 
cells were lysed and the CFU of the released bacilli was calculated. The data represent 
the results of the means ± SEM from three or more experiments.  
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3.3. EFFECT OF M. BOVIS BCG INFECTION ON eIF2α IN MURINE 
MACROPHAGES. 
 
To examine the effect of M. bovis BCG infection on eIF2α phosphorylation, 
RAW 264.7 cells were infected with live M. bovis BCG or heat-killed M. bovis BCG at 
an MOI of 10. Cell lysates were collected at 3 and 24h post infection, fractionated by 
SDS-PAGE electrophoresis, and analysed by immunoblotting using total and 
phospho-specific eIF2α antibodies. (Figure 3-2A) shows that 3 and 24h infection with 
live M. bovis BCG resulted in a marked increase of eIF2α phosphorylation that was 
greatest at 24h. At 3h post infection, eIF2α phosphorylation increased one fold and 
2.19 fold at 24h post infection (Figure 3-2B). In contrast, heat-killed M. bovis BCG 
resulted in only modest increase in the level of p-eIF2α at 24h. In agreement with the 
increase in eIF2α phosphorylation at 24h post infection, the level of ATF4 was also 
observed at this time point. Throughout the infection the levels of total protein 
remained constant as indicated by GAPDH level. Therefore M. bovis BCG infection 
induces the phosphorylation of eIF2α and up regulates the ATF4 translation level. 
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Figure 3-2 Effect of M. bovis BCG infection on eIF2α in murine macrophages. 
RAW246.7 macrophages were infected with M. bovis BCG at MOI 10, then harvested 
after 3 and 24hpi. Then RAW246.7 cell lysates were separated by SDS-PAGE and 
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blotted on nitrocellulose membrane with eIF2α and ATF4 antibodies. (A) Level of p- 
eIF2α, total eIF2α and ATF4 were measured by Western blot at the indicated times. 
GAPDH was used as a loading control. (B) Graph showing fold change in live M. bovis 
BCG induced eIF2α phosphorylation levels compared to uninfected (media only), data 
represent the means ± SEM from three experiments. 
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3.4. EFFECT OF M. BOVIS BCG INFECTION ON GLOBAL CELLULAR 
TRANSLATION. 
 
Immune cells like macrophages have established tightly regulated mechanisms 
to control their activity. In response to intra- and extracellular signals, these cells need 
to induce prompt changes in the proteome adapting to the rapid changes in the cellular 
environment. The understanding of host mRNA translation during microbial infection 
can give insights on translational control of the immunological function (Piccilliro et al., 
2014). The previous findings of increased eIF2α phosphorylation and ATF4 levels 
suggested that M. bovis BCG infection may induce global effects on host mRNA 
translation. Therefore, polysome profiling was used to estimate the translation 
efficiency in RAW264.7 cells during M. bovis BCG infection.  
Using centrifugation of cell lysates through sucrose density gradient, mRNAs 
bound to none, one or several ribosomes can be separated. The monosomal fractions 
correspond to single ribosomal subunits that are not translation-competent, found in 
the lighter fractions (fractions 2/3 for the 40S subunit, fractions 4/5 for the 60S subunit 
and 80S complexes) (Masek et al., 2011). The polysomes are translation-competent 
80S ribosome complexes found in the heavier fractions (fraction 6 to10). By comparing 
the relative abundance of polysomes to monosomes, the cell’s translational activity 
can be estimated. 
Cytoplasmic extracts from RAW264.7 cells infected with M. bovis BCG at a MOI 
of 10 were collected at 3, 18 and 24h post infection. They were then separated by 
centrifigation through a sucrose gradient, (Figures 3-3A, B and C) represent the A254 
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trace of the fractionated monosomes and polysomes from RAW264.7 cells lysates 
collected at 3, 18 and 24h post infection respectively. Following the fractionation, the 
ratio of polysome to monosome was calculated. (Figure 3-3D) shows that at 3h post 
infection, the polysome to monosome (p/m) ratio showed no significant difference 
between uninfected and M. bovis BCG-infected, while at 18h and 24h post infection 
there was a significant decrease in p/m ratios in M. bovis BCG-infected RAW264.7 
cells. These results suggest that M. bovis BCG infection results in reduced translation 
initiation in RAW264.7 murine macrophages. 
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Figure 3-3 Effect of M. bovis BCG infection on cellular translation. 
  
Polysome profiles of uninfected and M. bovis BCG infected RAW264.7 cell 
macrophages showing monosomes (fraction 2 to 5) and polysomes (fraction 6 to 10). 
(A) Represent 3hpi, (B) represent 18hpi and (C) represent 24hpi. (D) Polysome to 
Monosome ratios at each time point post infection. Note that the amount of material 
loaded varied at each time points. Unpaired student t-test was used to establish 
significance. *p < 0.05. 
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3.5.  EFFECT OF M. BOVIS BCG INFECTION ON 4EBPs. 
 
The availability of eIF4E is critically important for the activity of the translation 
initiation, as it is the least abundant initiation factor, thus the cap-binding represents a 
rate-limiting step during translation (Hershey et.al, 2000, Gert et.al, 2002, Svitkin et.al, 
2005). eIF4E interacts with inhibitory proteins called 4E-BPs, which sequester eIF4E 
and prevent its association with eIF4G and eIF4A to form the translation initiation 
complex eIF4F. There are three isoform of 4E-BP: 4E-BP1, 4E-BP2 and 4E-BP3, 4E-
BP1 is the most studied. In mammals, 4E-BPs undergo phosphorylation at multiple 
sites, Thr-37/46, Thr-70 and Ser-65 following activation of the PI3K/mTOR signalling 
pathway (described at section 1-2-1-2) (Haghighat & Sonenberg, 1997, Gert et.al, 
2002).  
To analyze the effect of M. bovis BCG infection on the phosphorylation status 
of 4EBP1, RAW264.7 macrophages were infected with M. bovis BCG at a MOI 10. 
Cell lysates from uninfected and M. bovis BCG-infected wells were collected at 3, 18 
and 24h post infection, fractionated by SDS-PAGE and analysed by immunoblotting 
for total and phospho-specific 4E-BP1 antibodies. As shown on (Figure 3-4A), M. bovis 
BCG mediated phosphorylation of 4EBP1 at Thr37/46 was increased compared to 
uninfected. However, M. bovis BCG infection resulted in the phosphorylation on Thr-
70 early in infection, while phosphorylation on Ser65 occurred later at 18 and 24h post 
infection. Throughout the time course the total protein level remained relatively 
constant as shown by the stable levels of the loading control GAPDH at 3, 18 and 24h 
post infection. (Figure 3-4B) showed a different onset of each 4E-BP1 phosphorylation 
residue in M. bovis BCG infected RAW264.7 cells, with significant increase in the 
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phosphorylation level on Thr70 at 3h followed by Ser65 at 18 and 24h post infection. 
To better understand the cellular signaling pathway driving 4E-BP1 phosphorylation, 
the activation of the PI3K-mTOR pathway was further evaluated using antibody arrays, 
a kinase profiler kit (R&D system, ARY003D). As shown on (Figure 3-4C), M. bovis 
BCG infection resulted in increased phosphorylation of Akt at Thr308, but mTOR 
phosphorylation on the apparent Akt phosphorylation site, Ser2484, and its substrate 
p70S6K showed no significant change in their phosphorylation levels at 18h post 
infection. Overall these results suggest that M. bovis BCG infection results in 
increased 4E-BP phosphorylation, which might be due to Akt activation. This is in 
contrast with the reduced translational activity observed in the previous experiments 
therefore, this raises questions as to the biological significance of the 4E-BP1 
activation observed.  
In summary, M. bovis BCG infection induces 4E-BP1 phosphorylation on Thr-
37, 46, Thr70 and Ser65 residues, which might occur through the activation of PI3K-
Akt-mTOR signalling pathway. 
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Figure 3-4 Effect of M. bovis BCG infection on 4EBP1 phosphorylation and 
upstream regulators. 
 
RAW246.7 macrophages were infected with live or heat killed M. bovis BCG at MOI 
10, and cell lysates were collected at 3, 18, 24hpi. Then RAW246.7 cell lysates were 
separated by SDS-PAGE, transferred on nitrocellulose membrane and probed with 
anti-4EBP1 antibodies. (A) Level of the total and phosphorylated 4EBP1 were 
measured by Western blot in the indicated time. GAPDH was used as a loading 
control. (B) Graph represents the pixel density of phosphorylated 4EBP1 at multiple 
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sites with a different onset of phosphorylation. (C) Using phospho-kinase arrays, the 
phosphorylated level of mTOR, p70S6 kinase, and Akt were measured in BCG 
infected cells for (18hpi), graph represents the means ± SEM from three experiments.  
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3.6. EFFECT OF M. BOVIS BCG INFECTION ON eIF4E PHOSPHORYLATION. 
 
The MAPK interacting kinases Mnk1 and Mnk2 can both phosphorylate eIF4E 
on Ser209, and this has been associated to mechanisms that control cell immunity. 
While Mnk2 is responsible for constitutive phosphorylation, Mnk1 is activated in 
response to various stimuli.  
To analyze the effect of M. bovis BCG infection on eIF4E, RAW264.7 
macrophages were infected with live- M. bovis BCG and heat killed- M. bovis BCG at 
a MOI 10. The lysates from uninfected and M. bovis BCG -infected cells were collected 
at 3, 18 and 24h post infection, fractionated by SDS-PAGE and analysed by 
immunoblotting for total and phospho-specific eIF4E antibodies.  
As shown on (Figure 3-5A), M. bovis BCG infection induces eIF4E 
phosphorylation on Ser209 in RAW264.7 macrophages throughout the infection time 
course. Meanwhile, the expression of eIF4E remained comparable in uninfected and 
infected cells throughout the time course, as well as the stable levels of the loading 
control GAPDH. At 3, 18 and 24 h post infection, the live M. bovis BCG induced 
phosphorylation levels increased by 3.5, 5 and 8 fold over the uninfected control, 
respectively. In contrast the heat-killed M. bovis BCG infection only resulted in eIF4E 
phosphorylation at 3 and 18 h, but much less at 24 h post infection (Figure 3-5B). 
Therefore, while both heat-killed and live M. bovis BCG infection result in eIF4E 
phosphorylation, only infection with live M. bovis BCG results in sustained 
phosphorylation which may reflect signaling events occurring following the 
internalization of live M. bovis BCG and its persistence replication in the cell. It is 
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important to note that heat-killed M. bovis BCG are likely to be degraded by the end 
of the infection time-course. 
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Figure 3-5 Effect of M. bovis BCG infection on eIF4E phosphorylation. 
. 
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RAW246.7 macrophages were infected with M. bovis BCG at MOI of 10, and cell 
lysates were collected at 3, 18, 24hpi. Then RAW246.7 cell lysates were separated by 
SDS-PAGE, transferred on nitrocellulose membrane and probed with anti-eIF4E 
antibodies. (A) Level of p-eIF4E and total eIF4E were measured by Western blot in 
the indicated time. GAPDH was used as a loading control (B) Graph shows 
quantification of P-eIF4E level in live M. bovis BCG and heat killed M. bovis BCG 
infected cells, data represent the means ± SEM of from three experiments  
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3.7. EFFECT OF PHAGOCYTOSIS ON eIF4E PHOSPHRYLATION. 
 
The process of phagocytosis is stimulated when the phagocytic particle 
interacts with cell membrane receptors, thereby initiating a variety of signalling 
cascades. To assess whether phagocytosis per se, rather than an effect driven by M. 
bovis BCG itself, could be responsible for eIF4E phosphorylation. Latex beads were 
used as a model to stimulate phagocytosis and eIF4E phosphorylation was measured. 
Latex beads were added to the RAW264.7 cell monolayer at a ratio of ten beads 
to each macrophage, and M. bovis BCG infection was conducted at MOI 10. Lysates 
from uninfected, latex beads treated, heat-killed and live M. bovis BCG-infected cells 
were collected at 3h, fractionated by SDS-PAGE and analysed by immunoblotting for 
total and phospho-specific eIF4E antibodies. In contrast to phosphorylation induced 
by both heat killed and live M. bovis BCG, the stimulation of phagocytosis with latex 
beads did not result in increased eIF4E phosphorylation (Figure 3-6A). Therefore, this 
result demonstrated that latex bead phagocytosis is not sufficient to activate signals 
resulting in eIF4E phosphorylation in RAW264.7 cell macrophages. 
 
3.8.  EFFECT OF TLR AGONISTS ON eIF4E PHOSPHORYLATION. 
 
Having shown that phagocytosis is not responsible for eIF4E phosphorylation 
during M. bovis BCG infection, the effect of M. bovis BCG binding to its cellular 
receptors TLR2 and TLR4 was investigated.  
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To evaluate the effect of TLR activation on the phosphorylation status of eIF4E, 
synthetic TLR agonists, Pam3CSK for TLR2 and LPS for TLR4, were used. RAW264.7 
cells were incubated with Pam3CSK or LPS at a concentration 1µg/ml and 0.1µg/ml, 
respectively. Lysates from uninfected, Pam3CSK, LPS and M. bovis BCG infected 
cells were collected at 1 and 3h, fractionated by SDS-PAGE and analysed by 
immunoblotting for total and phospho-specific eIF4E antibodies. 
As shown on (Figure 3-6B), the stimulation of RAW264.7 cells with M. bovis 
BCG or LPS or PAM3CYS for one hour showed that LPS treatment resulted in 
increased phosphorylation of eIF4E, with levels higher to those induced by M. bovis 
BCG and PAM3CYS. PAM3CYS stimulation for one hour only resulted in a lower 
phosphorylation level than that induced by M. bovis BCG infection. However, (Figure 
3-6C) showed at 3h no increase in eIF4E phosphorylation level in both LPS and 
PAM3CYS stimulated cells compared to their positive control (M. bovis BCG-infected). 
Thus, given that mycobacteria stimulate mostly through TLR2, this data suggests that 
stimulation of TLR4 induces more phosphorylation of eIF4E than TLR2 stimulation. 
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Figure 3-6 Effect of receptor activation on eIF4E phosphorylation. 
 
RAW246.7 macrophages were incubated in DMEM with and without latex beads 
(ratio10:1), LPS (0.1µg/ml), and PAM3CYS (1µg/ml) before cell harvest after 1 and 
3hours. Cells infected with M. bovis BCG at MOI 10 were used as a positive control. 
Then RAW246.7 cell lysates were separated by SDS-PAGE, blotted on nitrocellulose 
membrane and probed with anti-eIF4E antibodies. (A) Level of p-eIF4E and total 
eIF4E were measured by Western blot in cells pre-incubated with latex beads for 3h, 
(B) Level of p-eIF4E and total eIF4E were measured by Western blot in cells stimulated 
with TLR agonists for 1h. (C) Level of p-eIF4E and total eIF4E were measured by 
Western blot in cells stimulated with TLR agonists for 3h. GAPDH was used as a 
loading control. 
 
Chapter 3                The effect of M. bovis BCG infection on translation initiation 
 
110 
 
3.9. DISCUSSION  
 
Obligate intracellular pathogens like viruses hijack host translation machinery, 
inhibiting host mRNA translation but stimulating translation their own mRNA. The 
extent of the changes on host mRNA translation is dependent on the virulent of the 
pathogen, the cell type and the chronicity of the diseases. Even though intracellular 
bacteria and protozoa pathogens are not dependent on host translation components, 
their modulation of host translation can highlight mechanisms used to control host cell 
biology in favor of the pathogen. However, there is a paucity of information regarding 
the extent and mechanisms that bacteria and protozoa use to control host translation. 
(Mohr and Sonenberg, 2012). In this chapter, murine RAW264.7 macrophages were 
used as a model cell to investigate the changes in host mRNA translation initiation 
factors during M. bovis BCG infection. 
The eukaryotic initiation factor 2 is, a ribosomal binding protein, required for 
ternary complex (eIF2-GTP-Met-tRNAi) formation. Its phosphorylation at the α subunit 
inhibits translation initiation (as discussed in section 1-2-1-2). A previous study with 
mycobacterial infection demonstrated an increased eIF2α phosphorylation as a 
marker of ER stress (Lim. et al, 2011). In agreement, the results shown in this chapter 
demonstrate an increase of eIF2α phosphorylation on Ser51 in M. bovis BCG infected 
murine macrophages. It is well established that the translational stalling mediated by 
phosphorylated eIF2α is associated with increase in ATF4 translation. Furthermore, 
this increase in ATF4 expression in stress conditions acts a mechanism of the cell to 
adapt the stress such as amino acid starvation or ER stress (Scheuner et al., 2001, 
Harding et al., 2003). To assess whether eIF2α phosphorylation is associated with 
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translation inhibition, polysome profiling was conducted. The results suggest that M. 
bovis BCG induces translation inhibition, which is accompanied by an increased 
eIF2α-p and ATF4 expression. 
Additionally, 4E-BP1, is another translation regulatory protein has been 
investigated in M. bovis BCG infected murine macrophages. The results demonstrate 
that M. bovis BCG infection induces the phosphorylation of 4EBP1 on Thr37/46/70 
and Ser65. Consistent with this there was a significant increase in Akt phosphorylation 
which is known to phosphorylate downstream effectors, mTOR and p70S6 kinase. In 
addition, mTOR activation has been demonstrated to be required for 4E-BP1 
phosphorylation (Gingras et al., 1998). The increased 4EBP1 phosphorylation is 
known to induce the release of eIF4E, which compete with eIF4G for binding to a 
common binding site on eIF4E (Pause et al., 1994, Gingras et al., 2001), thus, relieving 
the translation block. My results demonstrate an increase in M. bovis BCG mediated 
phosphorylation of eIF4E at Ser209 throughout the infection time course. In contrast, 
the experiment also showed that activation of pattern recognition receptors using LPS, 
which is a TLR4 agonist, and PAM3CYS, which is a TLR2 agonist, can induce a 
transient increase in the phosphorylation status of eIF4E. This result is compatible with 
a recent study conducted by Schott et al., 2014, which concluded that translational 
regulation in macrophages stimulated with LPS is important for the induction of 
negative feedback loop to ensure a rapid and transient inflammatory response.  
However, M. bovis BCG infection seems to induce prolonged eIF4E phosphorylation, 
which might suggest a more prolonged inflammatory response that could lead to the 
activation of integrated stress response signaling. To further understand the 
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importance of eIF4E phosphorylation, the investigation of the signalling pathways 
driving this process was therefore conducted in the next chapter.  
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4. REGULATION OF EIF4E IN M. BOVIS BCG INFECTED MURINE 
MACROPHAGES. 
4.1. INTRODUCTION 
 
The results in Chapter 3 described the ability of M. bovis BCG to mediate 
changes in the phosphorylation status of eIF4E at Ser209. MNK1 and MNK2 kinases 
are serine/threonine kinases, containing a MAPK binding site on the C-terminal 
domain that can be activated by ERK or p38 MAPK in response to external stimuli to 
phosphorylate eIF4E (Parra et al., 2005, Pyronnet, 2001). However, other additional 
kinases can modulate their activity via phosphorylation at alternative sites. MNK2 
exhibits a high basal activity and is resistant to ERK and p38 inhibitors (Scheper et al., 
2001). MNK1 is more sensitive towards external stimuli and contains the conserved 
phosphorylation sites located at Thr197 and Thr202 in mice (Shveygert et al., 2010). 
MNK2 also has the ability to phosphorylate eIF4E on Ser209, but to lesser extent than 
MNK1 (Pyronnet, 2001). 
Therefore, to understand the role of M. bovis BCG -induced eIF4E 
phosphorylation in RAW264.7 cells, the activity of the MAPK kinases regulating eIF4E 
phosphorylation was studied, alongside the effect of kinases-specific inhibitors on 
pathogen replication. The aims of this chapter are to: 
1. Investigate the effect of M. bovis BCG infection on MNK activity in murine 
macrophages. 
2. Study the effect of inhibiting MNK activity and thus eIF4E phosphorylation on 
survival of M. bovis BCG 
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3. Study the importance of ERK and p38 activity in M. bovis BCG-infected murine 
macrophages. Specifically this included investigation of the: 
 Activity of ERK and p38 kinases in M. bovis BCG -infected murine 
macrophages. 
 Impact of ERK inhibition on eIF4E phosphorylation and M. bovis BCG 
replication in infected cells 
 Impact of p38 inhibition on eIF4E phosphorylation and M. bovis BCG 
replication in infected cells. 
 
4.2. EFFECT OF M. BOVIS BCG INFECTION ON MITOGEN-ACTIVATED 
PROTEIN KINASE-INTERACTING KINASE.  
 
To analyze the importance of eIF4E phosphorylation during M. bovis BCG 
infection, Mnk1 activity in M. bovis BCG infected RAW264.7 cells was monitored. To 
this end, cell lysates from uninfected and M. bovis BCG -infected RAW264.7 at 3, 18 
and 24h post infection, were fractionated by SDS-PAGE and analysed by 
immunoblotting with total and phospho-specific MNK1 antibodies.  
Figure (4-1A) shows that at 3h post infection, live M. bovis BCG induced MNK1 
phosphorylation, while heat-killed BCG had no effect on MNK1 phosphorylation. At 
both 18 and 24h post infection, live and heat-killed M. bovis BCG induced Mnk1 
phosphorylation, although live M. bovis BCG seemed to induce a greater level of 
phosphorylation. Throughout the time course the total MNK1 protein level remained 
constant as shown by the stable levels at 3, 18 and 24h post infection. 
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In order to investigate the role of Mnk1 in eIF4E phosphorylation and its 
importance for M. bovis BCG survival, CGP57380, a specific Mnk1 inhibitor, was used. 
First, RAW264.7 cells were treated with 0 to 40 μM CGP 57380 to assess the inhibitor 
effect on macrophage viability. As shown on (Figure 4-1B), at the concentrations 
tested, CGP57380 had no effect on macrophage viability. Next, M. bovis BCG-infected 
RAW264.7 cells were treated with 20 μM of CGP57380 and analyzed by 
immunoblotting. The addition of CGP57380 was able to reduce eIF4E phosphorylation 
to level similar to uninfected cells (Figure 4-1C). Thus, pharmacological inhibition of 
Mnk1 inhibits eIF4E phosphorylation in M. bovis BCG-infected cells.  
To further understand the importance of eIF4E phosphorylation on M. bovis 
BCG replication, we analyzed the impact of Mnk1 inhibition on bacterial survival. The 
bacterial load in infected macrophages was calculated by serial dilution using the Miles 
and Misra calculation method as described in the methods (section 2-14). The addition 
of 20 μM CGP57380 to M. bovis BCG-infected RAW264.7 cells made no change on 
the intracellular as well as extracellular BCG recovery at 24h post infection (Figure 4-
1D). While (Figure 4-1E) showed a significant increase in the CFU of intracellular BCG 
per macrophage from an average of 0.7 in BCG infected macrophages to 1.7 in 
CGP57380 treated macrophages, which was associated with a decreased 
macrophage viability at the same time point (24h post infection).  
Thus, this result suggests that inhibiting eIF4E phosphorylation does not impact 
on M. bovis BCG replication although, inhibiting MNK1 phosphorylation with 
CGP57830 resulted in reduced macrophage viability during M. bovis BCG infection.  
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There is a discrepancy in the literature, with both virulent and avirulent M. 
tuberculosis being shown to stimulate and inhibit apoptosis of infected macrophages 
in different settings (Keane et.al, 2000, Derrick et.al, 2007, Velmurugan et.al, 2007). 
Previous studies at Surrey have demonstrated that infection with non-pathogenic 
mycobacterium inhibits apoptosis in the infected host in an MOI-dependent manner 
and period of infection (Butler et al., 2012). Therefore, further study of eIF4E 
phosphorylation impact on macrophage survival during M. bovis BCG infection is 
needed to verify the rule of MNK/eIF4E phosphorylation on host cell death pathway. 
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Figure 4-1 Effect M. bovis BCG infection on Mnk1 activity and the effect of MNK1 
activity on M. bovis BCG and macrophage viability/replication 
 
 (A) RAW264.7 macrophages were infected with live or heat killed M. bovis BCG at a 
MOI 10. Cell lysates were separated by SDS-PAGE, blotted on nitrocellulose 
membrane and probed with anti-MNK1 antibodies to assess the level of total and 
phosphorylated MNK1 at 3, 18, 24h. GAPDH was used as a loading control. (B) 
Validation of CGP 75380 MNK inhibitor concentrations on macrophage viability. Graph 
represent macrophage viability was measured by CellTiter-Glo® luminescent cell 
viability assay (Promega). Viability is expressed as a percentage of the DMSO control 
set to 100%. Results show the means ± SEM from three separate experiments. (C) 
RAW264.7 cells were infected with M. bovis BCG for 24h at a MOI of 10 with or without 
20 μM CGP 75380, DMSO was used as vehicle. Cell lysates were analyzed by 
immunoblotting, using anti-eIF4E antibodies. (D) RAW264.7 cells were infected with 
M. bovis BCG for 24h at a MOI of 10 with or without 20 μM CGP 75380. The cells 
lysates and culture supernatant were collected and CFU was calculated. (E)The 
number of intracellular BCG per macrophage, then macrophage viability was 
measured.  The graphs show the results of three separate experiments *, p < 0.05; **, 
p < 0.01; ***, p < 0.001.  
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4.3. EFFECT OF M. BOVIS BCG INFECTION ON MITOGEN-ACTIVATED 
PROTEIN KINASE (ERK1/2 AND P38MAPK). 
 
The three known effector arms of the MAP kinase family include the 
extracellular regulated kinase ERK1/2, the stress-activated kinases JNK/SAPK and 
p38MAPK, which all play a central role in transducing the external signals into 
intracellular responses. Previous studies have demonstrated that both ERK1/2 and 
p38MAP kinases regulate MNK activity and eIF4E phosphorylation in response to 
external stimulus (Roux et al., 2012). Therefore, the activity of ERK1/2 and p38MAP 
kinases was analysed during M. bovis BCG infection. To this end, RAW264.7 cells 
were uninfected or M. bovis BCG-infected for 1, 3, 18 or 24h, and cell lysates were 
fractionated by SDS-PAGE followed by immunoblotting with total and phospho-
specific ERK1/2 and p38MAPK antibodies. 
At both 1 and 3h post infection, M. bovis BCG infection did not result in 
p38MAPK phosphorylation, however later at 18 and 24h post infection, M. bovis BCG 
infection induced a phosphorylation of p38 at the Thr180/Tyr182 residues (Figure 4-
2). No p38MAPK phosphorylation was detected in the uninfected control. In contrast, 
M. bovis BCG infection induced an early increase in the phosphorylation level of 
ERK1/2 that remained above the uninfected background throughout infection, despite 
a slight decrease at 24h post infection. The total level for both p38MAPK and ERK1/2 
remains constant during the 24h infection, as well as the level of GAPDH used as a 
loading control. Therefore, M. bovis BCG infection induces a rapid early increase in 
the phosphorylation status of ERK1/2, and a later induction of p38MAPK activity in 
RAW264.7 cells. 
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Figure 4-2 Effect of M. bovis BCG on MAPK activity in RAW264.7 macrophages. 
 
Macrophages were infected with live M. bovis BCG at MOI 10 and cell lysates were 
separated by SDS-PAGE, blotted onto nitrocellulose membrane and probed with anti-
ERK/p38MAPK antibodies. The level of total and phosphorylated ERK/p38MAPK were 
measured by Western blot at the indicated time. GAPDH was used as a loading 
control. 
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To further understand whether M. bovis BCG stimulation of PRR such as TLR2, 
is sufficient to drive the activation of the MAP kinases effectors ERK1/2 and p38MAPK, 
or whether active infection with live bacteria is required, RAW264.7 cells were infected 
with live or heat-killed M. bovis BCG. Cells lysates collected at 3, 18 and 24h post 
infection were fractionated by SDS-PAGE and analysed by immunoblotting for total 
and phospho-specific ERK1/2.  
As noted in (Figure 4-2), RAW264.7 cells infection resulted in an increased 
phosphorylation of ERK1/2 at 3 and 18h post infection, while at 24h post infection p-
ERK remained higher than the uninfected background but decreased from 18h post 
infection (Figure 4-3A). In contrast, infection which heat-killed M. bovis BCG resulted 
in a gradual increase of ERK1/2 phosphorylation over the 24h infection period. 
Quantification of the immunoblotting experiments, confirmed that for all time points, 
live or heat-killed M. bovis BCG induced significant ERK1/2 phosphorylation increase, 
and this increase was more for live M. bovis BCG than heat-killed at both 3 and 18h 
post infection, while it is less at 24h post infection (Figure 4-3B).  
These results confirmed that M. bovis BCG infection results in the activation of 
ERK1/2 phosphorylation, and that stimulation of PRR such as TLR2, is a significant 
contribution to ERK1/2 activation. However, M. bovis BCG intracellular replication 
stimulates a quicker activation of ERK1/2, which may lead to an altered macrophage 
phenotype. 
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Figure 4-3 Effect of M. bovis BCG infection on ERK phosphorylation in RAW264.7 
macrophages. 
 
(A) RAW264.7 macrophages were infected with live and heat killed M. bovis BCG at 
MOI 10 and cell lysates were separated by SDS-PAGE, blotted onto nitrocellulose 
membrane and probed with anti-ERK antibodies. The level of total and phosphorylated 
ERK were measured by Western blot at the indicated times. GAPDH was used as a 
loading control. (B) Quantification of immunoblotting intensity changes of p-ERK1/2. 
Results show the means ± SEM from three separate experiments. 
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4.4. INHIBITION OF MITOGEN ACTIVATED PROTEIN KINASES (MAPK) 
ERK1/2 AND P38MAPK IN M. BOVIS BCG INFECTED MURINE 
MACROPHAGES. 
 
To further understand the role of ERK1/2 and p38MAPK during M. bovis BCG 
infection, we used two pharmacological inhibitors, SCH772984 and SB203580 of 
ERK1/2 and p38MAPK, respectively.  
 
4.4.1. DISSECTING THE IMPACT OF ERK1/2 INHIBITION ON MNK/eIF4E 
PHOSPHORYLATION AND M. BOVIS BCG REPLICATION. 
 
As shown previously in (Figure 4-3), M. bovis BCG infection of macrophages 
induces ERK1/2 phosphorylation early during infection. To analyse the role of ERK1/2 
on the MNK/eIF4E phosphorylation observed during infection, cells were treated with 
the chemical ERK inhibitor SCH772984. SCH772984 is a potent and selective ERK 
inhibitor previously developed for treating malignancies dependent on dysregulated 
MAPK signaling (Morris et al., 2013)  
First RAW264.7 cells were treated with 0 to 20 μM SCH772984, and the impact 
on macrophage viability was measured. At the concentrations tested, SCH772984 had 
no effect on macrophage viability (Figure 4-4A), therefore 20 μM was chosen for 
further studies. RAW264.7 cells where then treated for a hour with 20 μM SCH772984, 
and then uninfected or M. bovis BCG-infected for 24h. Cells lysates were fractionated 
by SDS-PAGE and analyzed by immunoblotting. While SCH772984 had no impact on 
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total MNK1 or eIF4E level, it blocked the induction of MNK1 and eIF4E 
phosphorylation observed in DMSO-treated M. bovis BCG-infected cells (Figure 4-
4B). Thus, pharmacological inhibition of ERK can inhibit MNK1 and eIF4E 
phosphorylation in M. bovis BCG infected cells to that of uninfected cells. Therefore 
this suggest that during infection, ERK1/2 is responsible for driving MNK1 activation 
and eIF4E phosphorylation.  
Next, the impact of ERK1/2 inhibition on bacterial replication was analysed by 
measuring bacterial CFU using the Miles and Misra method. The addition of 20 μM 
SCH772984 to M. bovis BCG-infected RAW264.7 cells resulted in reduced number of 
intracellular recovered M. bovis BCG at 24 h post infection (Figure 4-4C), without a 
significant change in the number of extracellular bacterial CFU, suggesting that 
ERK1/2 activation is important for M. bovis BCG infection. Figure 4-4D showed no 
change in the number of bacterial CFU per macrophage despite a significant reduction 
in the number of infected viable macrophage, therefore the reduction in the 
intracellular CFU might suggest an induction of macrophage cell death associated with 
the killing of the M. bovis BCG in the SCH772984 pretreated cells (Figure 4-4D). 
Overall, these finding suggest that inhibiting ERK, MNK and eIF4E phosphorylation is 
important for M. bovis BCG infection by restricting its presence in the permissive 
intracellular niche, and that inhibiting the ERK pathway could be responsible for this 
through inducing macrophage cell death. 
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Figure 4-4 Effect of ERK inhibition on M. bovis BCG induced Mnk/eIF4E 
phosphorylation in RAW264.7 macrophages. 
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(A) RAW264.7 cells were treated with SCH772984, was used as an ERK inhibitor. 
Graph represent macrophage cytotoxicity using CellTiter-Glo® luminescent cell 
viability assay (Promega). Macrophage viability is expressed as a percentage of the 
DMSO control set to 100%. (B) RAW264.7 cells were infected with M. bovis BCG for 
24h at an MOI of 10 with or without 20 μM SCH772984, DMSO was used as vehicle. 
Cell lysates were analyzed by immunoblotting. The level of total and phosphorylated 
MNK1/eIF4E were measured by Western blot. (C) RAW264.7 cells were infected with 
BCG for 24h at MOI of 10 with or without 20 μM SCH772984. The cells lysates and 
culture supernatant were collected and CFU was calculated. (D) BCG CFU were 
calculated per macrophage (Left). Macrophage viability was expressed as a 
percentage of the DMSO control set to 100% (Right). Results show the means ± SEM 
from three separate experiments, *, p < 0.05; **, p < 0.01; ***, p < 0.001. 
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4.4.2. DISSECTING THE IMPACT OF P38MAPK INHIBITION ON MNK/eIF4E 
PHOSPHORYLATION AND M. BOVIS BCG REPLICATION. 
 
M. bovis BCG infection induces a late induction of p38MAPK phosphorylation 
during infection (Figure 4-2). To analyse the importance of p38MAPK phosphorylation 
on MNK/eIF4E phosphorylation and M. bovis BCG survival, the p38MAPK inhibitor 
SB203580 was used. SB203580 is a highly selective p38MAPK inhibitor showed an 
efficacy to treat chronic inflammatory diseases, such as rheumatoid arthritis in animal 
models (Davies et al., 2000).  
First, RAW264.7 cells were challenged with increasing concentrations of 
SB203580 from 0 to 20 μM, followed by macrophage viability assays. At all the 
concentration tested, SB203580 had no effect on macrophage viability (Figure 4-5A). 
RAW264.7 cells were challenged 20 μM of SB203580 or DMSO, and then uninfected 
or M. bovis BCG-infected for 3 or 24h, or treated with LPS as a positive control. Cell 
lysate were then fractionated by SDS-PAGE and analyzed by immunoblotting.  As 
expected, SB203580 is able to inhibit LPS-induced eIF4E phosphorylation (Figure 4-
5B). In contrast, at both 3 and 24h post infection, SB203580 treatment did not impact 
on the level of eIF4E and MNK1 phosphorylation. Therefore, p38MAPK inhibition does 
not revert M. bovis BCG-induced eIF4E phosphorylation suggesting that p38MAPK 
activation during infection has little impact on eIF4E-mediated translational control and 
that the activation of ERK1/2 is more critical to eIF4E activity.  
To evaluate the importance of p38MAPK activation on M. bovis BCG survival, 
the impact of SB203580 on M. bovis BCG replication was calculated using the Miles 
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and Misra method. The addition of 20μM SB203580 to M. bovis BCG-infected 
RAW264.7 cells did not affect the number of intracellular recovered M. bovis BCG from 
the macrophages at 24h post infection (Figure 4-5C), while a significant increase in 
the number of BCG recovered from the culture supernatant. In addition, a significant 
decrease in the number of viable macrophages was observed (Figure 4-5D) which 
might be the cause of increasing the extracellular CFU in SB203580 treated cells, due 
to the release of the bacilli from the lysed cells. Thus, this suggests that inhibiting 
p38MAPK activity does not impair M. bovis BCG replication. 
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Figure 4-5 Effect of P38MAPK inhibition on M. bovis BCG induced MNK/eIF4E 
phosphorylation in RAW264.7 macrophages 
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(A) RAW264.7 cells were treated with SB203580, used as a p38MAPK inhibitor. Graph 
represent macrophage viability using CellTiter-Glo® luminescent cell viability assay 
(Promega). Viability is expressed as a percentage of the DMSO control set to 100%. 
(B) RAW264.7 cells were infected with BCG for 24h at MOI of 10 with or without 20 
μM SB203580, DMSO was used as vehicle and LPS (10ng/ml) treated RAW264.7 cells 
for 3h was used as a positive control. Cell lysates were analyzed by immunoblotting. 
The level of total and phosphorylated MNK/eIF4E were measured by Western blot. 
GAPDH was used as a loading control. (C) RAW264.7 cells were infected with M. 
bovis BCG for 24h at MOI of 10 with or without 20 μM SB203580. The cells lysates 
and culture supernatant were collected and CFU was calculated. The figure shows the 
results of one experiment *, p < 0.05; **, p < 0.01; ***, p < 0.001. (D) RAW264.7 cells 
were infected with M. bovis BCG for 24h at MOI of 10 with or without 20 μM SB203580. 
Macrophage viability is expressed as a percentage of the DMSO control set to 100%. 
Results show the means ± SEM from three separate experiments. 
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4.5. DISCUSSION 
 
Several viral pathogens have developed strategies to manipulate the host cell 
translation system by stimulating the activity of MAP kinases that control eIF4E activity 
(Mohr & Sonenberg, 2012). The activity of eIF4E is modulated via phosphorylation on 
Ser209 residue, which then impacts on the regulation of mRNA translation. 
Furthermore, the control of phosphorylation has previously been shown to play a role 
in the innate immune response to pathogens by controlling chemokines expression 
(Piccirillo et al., 2014), eIF4E phosphorylation has also been linked with cell survival 
and proliferation in cancer through the stimulation of specific mRNA involved in 
angiogenesis, proliferation and inhibition of apoptosis (Furic et al., 2010). 
Having demonstrated in chapter 3 that M. bovis BCG infection induces eIF4E 
phosphorylation, the effect of the upstream kinases MNK1, ERK1/2 and p38MAPK 
were studied in this chapter. Upon infection of macrophages with M. bovis BCG, the 
MAP kinases MNK1, ERK1/2 and p38MAPK are all activated with the ERK1/2 
activation occurring within 3h post infection, and p38MAPK activation occurring later 
at 24h post infection. We confirmed that eIF4E phosphorylation during infection is 
driven via MNK1 activation by showing that MNK1 pharmacological inhibition can 
revert the M. bovis BCG -induced phosphorylation. 
To then understand which arm of the MAPK pathway is responsible for eIF4E 
phosphorylation, both ERK1/2 and p38MAPK were inhibited with pharmacological 
inhibitors. Unlike SB203580-mediated inhibition of p38MAPK, SCH772984-mediated 
inhibition of ERK1/2 reverted eIF4E phosphorylation during infection. This suggest that 
ERK1/2, and not p38MAPK, is responsible for M. bovis BCG-induced eIF4E 
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phosphorylation. A recent study by Royall et al., 2015 demonstrated that norovirus 
infection resulted in p38MAPK-driven activation of MNK1 and eIF4E phosphorylation, 
playing a role in viral replication via specific translational control. Interestingly this virus 
activates eIF4E phosphorylation via p38MAPK while M. bovis BCG, a bacteria, 
activates eIF4E phosphorylation via ERK1/2. Thus the differential activation of TLRs 
by viruses and bacteria could explain the different routes leading to eIF4E 
phosphorylation.  
Further experiments showed that both heat-killed and live M. bovis BCG can 
induce ERK1/2 and MNK1 phosphorylation, but that the phosphorylation was more 
from live M. bovis BCG indicating that there is an active process contributes to the 
activation of the MAP kinase pathway, and this interaction is not simply driven by 
ligation of PRR with mycobacterial cell wall molecules. Although live M. bovis BCG 
induces an ERK1/2 phosphorylation at early time points, it declined later on, and this 
could be due to the stimulating a negative feedback loop. 
The phosphorylation of ERK1/2 is important for M. bovis BCG infection, as 
shown by the reduction in the number of recovered intracellular bacterial CFU 
following pharmacological inhibition of ERK kinase. Furthermore, inhibition of both 
MNK and ERK kinases also resulted in reduced macrophage survival during infection 
which suggest M. bovis BCG inhibition of apoptosis might be mediated through 
eIF4E/MNK/ERK pathway activation. This will need to be further investigated by 
measuring the number of apoptotic cells during infection in the presence or absence 
of MNK and ERK inhibitors. 
 In agreement with these results, p38MAPK inhibition had no impact on M. bovis 
BCG -driven eIF4E phosphorylation.  
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Overall these results suggest that M. bovis BCG infection control cellular translation 
during infection by activating the phosphorylation of eIF4E through the MAP kinase 
pathway to ensure survival within the host.  
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5. THE ROLE OF ERK, MNK, eIF4E PHOSPHORYLATION ON MYCOBACTERIAL 
INFECTION PATHOGENESIS 
 
5.1. INTRODUCTION. 
The results presented in chapter 3 and 4 the results suggested that during 
mycobacterial infection of macrophages, the MAPK pathway activates eIF4E 
phosphorylation. Furthermore, the kinases ERK and MNK were shown to be 
responsible for the eIF4E phosphorylation, which contributed to global changes in the 
host translational state, as identified by polysome profiling. These changes alter the 
macrophage response to mycobacteria, affecting intracellular bacterial survival/growth 
and macrophage viability. Thus, we propose that regulating eIF4E phosphorylation is 
a key component of the hostpathogen interaction during infection with pathogenic 
mycobacteria. 
 
To further test this hypothesis, this chapter will address the following aims: 
1. To investigate the effect of ERK and MNK inhibition on TNFα and IL-10 
production in RAW264.6 macrophages during M. bovis BCG infection. 
2. To investigate the effect of ERK and MNK inhibition on mycobacterial 
phagosomal acidification in RAW264.7 macrophages. 
3. To investigate the effect of ERK inhibition on the induction of autophagy marker 
(LC3) in RAW264.7 macrophages during M. bovis BCG infection. 
4. To investigate the effect of ERK inhibition on caspase-3/-7 activation in 
RAW264.7 macrophages during M. bovis BCG infection. 
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5.2. MYCOBACTERIUM-STIMULATED MAPK SIGNALLING REGULATES TNFα 
AND IL-10 PRODUCTION. 
 
The results from Chapter 3 and 4 indicated that eIF4E phosphorylation driven 
by the ERK-MNK signalling axis has an important role during M. bovis BCG infection. 
Furthermore, given the previous studies suggesting that the translation control and 
regulation of eIF4E are crucial in the immune response (Piccirillo et al., 2014), we 
hypothesise that MAPK signalling activation could be important in the control of 
cytokines production during M. bovis BCG infection. Thus, we tested the impact of the 
MAPK pathway on the production of TNF and IL10.  
IL10 is an anti-inflammatory cytokines secreted in response to mycobacteria 
infection in macrophages (Orme et al., 2015). In contrast, TNF plays a crucial dual 
role, as a pro-inflammatory cytokine controlling granuloma formation but also exerting 
a stimulating effect on mycobacteria transmission by inducing tissue damages and the 
formation of necrotic lesions (Russell, 2009).  
 
To evaluate the potential role of ERK and its downstream substrate MNK in the 
production of TNFα and IL10 in mouse macrophages, RAW264.7 cells were infected 
or stimulated by M. bovis BCG or LPS, respectively, for 3, 18 or 24h, in the presence 
or absence of the MNK inhibitor CGP57380, or the ERK inhibitor SCH772984.  
Following treatment, the culture medium was collected to determine the levels of TNFα 
and IL10 by ELISA. As expected, LPS stimulation led to the constant induction of TNFα 
production at 3h, 18h and 24h post treatment. The inhibition of MNK was able to totally 
revert the stimulation of TNFα production to baseline level (Figure 5-1A). In 
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comparison, M. bovis BCG infection leads to a gradual increase in TNFα production 
from 3h to 24h post infection which significantly reduced with MNK inhibition (Figure 
5-1B). Unlike, for LPS-driven stimulation, inhibiting MNK only reverted partially the M. 
bovis BCG-driven induction of TNFα production at 18 and 24h post-infection (Figure 
5-1B). In contrast, the inhibition of ERK had a more potent effect in reverting TNFα 
production following M. bovis BCG infection (Figure 5-1C). Therefore, this suggest that 
MNK activation, and thereby eIF4E phosphorylation is important, but is not the only 
driving force, in M. bovis BCG-induced activation of TNFα.  
LPS stimulation also resulted in the production of IL10 at 3 and 18h post 
treatment but not 24h. Similar to TNFα, the inhibition of MNK was sufficient to revert 
LPS-induced IL10 production (Figure 5-1D). In comparison, M. bovis BCG infection 
only lead to IL10 induction at 24h post infection, while none was detectable at 3 and 
18h post infection. This induction was also susceptible to MNK inhibition which lead to 
the reversal of IL10 production to background levels (Figure 5-1E). In contrast, ERK 
inhibition by the addition of SCH772984 alone induced IL10 production to level similar 
to that of M. bovis BCG infection (Figure 5-1F). However, ERK inhibition at 24h post 
infection was able to revert IL10 induction to background levels, unlike at 3 and 18h.  
Overall these results suggests that the M. bovis BCG-mediated activation of 
ERK and MNK are important in the control of TNFα and IL10 and that, eIF4E 
phosphorylation could play a role in controlling their production given that MNK 
inhibition impairs IL10 and TNF production during infection.  
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Figure 5-1 Regulation of cytokine production by ERK and MNK signalling in M. bovis 
BCG infected cells. 
 
The effects of protein kinase inhibitors on M. bovis BCG induced TNFα production 
were assessed using a commercial ELISA kit. Culture supernatants of RAW264.7 
macrophages were collected at 3, 18, 24h post-infection. (A) Cells were stimulated by 
LPS (0.1µg/ml) with or without CGP57380 (20µM) or, (B) infected with M. bovis BCG 
with or without CGP57380 (20µM). (C) Cells were infected with BCG with or without 
SCH772984 (20µM). Culture supernatants of RAW264.7 macrophages were collected 
at 3, 18, 24h post-infection to measure IL-10 production. (D) Cells stimulated by LPS 
(0.1µg/ml) with or without CGP57380 (20µM), (E) infected with M. bovis BCG with or 
without CGP57380 (20µM). (F) Cells were infected with M. bovis BCG with or without 
SCH772984 (20µM). Results represent the means ± SEM from three experiments. 
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5.3. ERK BUT NOT MNK KINASE CONTROLS MYCOBACTERIAL 
PHAGOSOME ACIDIFICATION. 
 
Phagosome formation plays a central role in the microbicidal functions of 
macrophages. The phagocytosis of most bacteria results in envelopment of the 
bacteria in a membrane bound phagosome that fuses with lysosomes becoming acidic 
and hydrolytic resulting in death of the microbe. Following phagocytosis, mycobacteria 
are able to establish infection through arresting phagosome maturation and avoiding 
the consequences of delivery to the phago-lysosome. Here, an acidotropic fluorescent 
dye was used to assess the phagosomal acidity as a marker of phagosome 
maturation. 
In order to investigate the effect of ERK and MNK inhibition on mycobacterial 
phagosome acidification, RAW264.7 cells were infected with FITC-labeled M.  bovis 
BCG. Cells were subjected to the ERK or MNK inhibitor 1 hour pre-BCG infection then 
infected with M. bovis BCG for 3h. The acidification of mycobacterial phagosomes was 
examined using the acidotropic fluorescent dye LysoTracker, that accumulates in 
acidic organelles.  
Fluorescent microscopy analysis revealed that 27% of live M. bovis BCG 
colocalized with LysoTracker, whereas 74% of heat-killed M. bovis BCG co-localized 
with LysoTracker (Figure 5-2A). Thus as expected live mycobacteria has the capacity 
to inhibit phagosome maturation. Following treatment with the MNK inhibitor 
CGP57380, no significant change in M. bovis BCG colocalization with LysoTracker 
(23%) was observed. However, when ERK using SCH772984 was inhibited 70% of 
M. bovis BCG were colocalized with lysoTracker (Figure 5-2B). This effect was evident 
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even with SCH772984 concentrations of 5-10µM, which are lower than the level 
required to inhibit eIF4E phosphorylation (Figure 5-2C). Thus, these result suggest 
that the action of ERK on phagosome maturation is independent from its effect on 
eIF4E phosphorylation during infection.  
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Figure 5-2 Effect of ERK and MNK on acidification of M. bovis BCG containing 
phagosomes 
 
(A) RAW264.7 macrophages were either uninfected, or infected with heat-killed FITC-
labelled M. bovis BCG or live FITC-labelled M. bovis BCG, at an MOI of 10 for 3h then 
incubated with LysoTracker for one hour. Activation of phagosomal acidity was 
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assessed using confocal microscopy, with representative images displaying 
phagosomes (LysoTracker, red), M. bovis BCG (FITC, green). Graph represents 
quantitative analysis of LysoTracker co-localization with M. bovis BCG. Data represent 
means ± SEM from triplicate experiments. *p ≤ 0.05. (B) Experiments were carried out 
as in (A) for infection with live FITC-labelled M. bovis BCG in the presence of 20 M 
CGP57380 or 20 M SCH772984. (C) Experiments were carried out as in (A) for 
infection with live FITC-labelled M. bovis BCG in the presence of either 5 M or 10 M 
SCH772984. 
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5.4. ERK REGULATES AUTOPHAGY IN BCG INFECTED CELLS. 
 
A previous study by Gutierrez et al., 2004 demonstrated that stimulation of 
autophagy by physiological or pharmacological means promoted the maturation of 
mycobacterial phagosomes, induced phagosome acidification and overcame the M. 
tuberculosis-induced phago-lysosome biogenesis block in a PI3K-dependent manner 
and concomitantly suppressed mycobacterial survival. However, this study 
characterized autophagy stimulated by the IFNγ pathway and mTOR signalling but not 
by MAPK. In this chapter, to characterize the role of ERK activation on autophagy, the 
autophagy marker LC3 was examined in M. bovis BCG infected RAW264.7 
macrophages with and without the ERK inhibitor SCH772894. LC3 has been shown 
to exist in two forms: the18 kDa cytosolic form (LC3-I) and the 16 kDa processed form 
(LC3-II) located on the autophagosomal membrane (Kabeya et al., 2000). 
RAW264.7 cells were infected in the absence or presence of SCH772984. Cell 
lysates were prepared, fractionated by SDS-PAGE and analysed by Western blotting 
using either LC3B I/II or GAPDH antibodies. The immunoblotting revealed increased 
levels of LC3-II in M. bovis BCG infected RAW264.7 lysates in the presence of 
SCH772984, compared to M. bovis BCG-infected only cells. As a positive control, cells 
grown in amino-acid starved media showed increased LC3-II (Figure 5-3A) 
These results were confirmed by immunofluorescent staining using LC3 
antibodies. RAW64.7 cells were treated with DMSO or SCH772894 for 1h then 
infected with M. bovis BCG for another 3h with DMSO or SCH772894. Again, 
RAW264.7 macrophages were subjected to amino-acid starvation as a positive control 
for autophagy in this experiment. By using confocal microscopy, LC3 puncta formation 
Chapter 5        The Role of ERK, MNK, eIF4E phosphorylation on Mycobacterial Infection Pathogenesis 
  
146 
 
was observed. LC3 staining was observed in the amino-acid starved cells (Figure 5-
3B). Very little LC3 staining was seen in M. bovis BCG infected cells, but when ERK 
was inhibited there were large and numerous LC3 puncta (Figure 5-3B). Furthermore, 
these changes were not observed in MNK inhibitor treated cells, when infected with 
M.bovis BCG (data not shown). 
 
Thus, the inhibition of ERK promotes LC3 formation in BCG infected RAW264.7 
macrophages indicative of autophagy. This increased autophagy may be responsible 
for the increased frequency of M. bovis BCG colocalization with acidic compartments 
observed in the previous section. Therefore these results could suggest that increased 
signalling via ERK but not MNK regulate the inhibition of autophagy during M. bovis 
BCG infection and that this effect is independent from the ERK-MNK driven eIF4E 
phosphorylation. 
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Figure 5-3 Induction of autophagy marker LC3 in M. bovis BCG infected RAW264.7 
cells. 
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RAW264.7 macrophages were untreated or pretreated with SCH772984 (20µM) or 
DMSO for 1h, then infected with M. bovis BCG at an MOI of 10 for 3h. To starve the 
cells, RAW246.7 cells were incubated in starvation media for 3h. Cell lysates were 
used as a positive control of autophagy. (A) RAW246.7 cell lysates were separated by 
SDS-PAGE, blotted on nitrocellulose membrane and probed with anti-LC3 and 
GAPDH antibodies. (B) RAW cells infected with FITC labelled M. bovis BCG (as 
indicated above) were fixed, permeabilized and incubated with antiLC3 antibodies, 
followed by ALEXA-555 conjugate secondary antibodies. Confocal images showing 
LC3 (red), M. bovis BCG (green) and DAPI were used to stain nuclei.  
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5.5. ERK INHIBITION PROMOTES CASPASE ACTIVITY IN M. BOVIS BCG 
INFECTED RAW264.7 CELLS. 
 
The mode of cell death induced by M.tuberculosis has been demonstrated to 
play a pivotal role in disease transmission. The most robust mycobacterial effect on 
host cell death is an ability of the bacterium to inhibit macrophage apoptosis (Butler et 
al., 2012) Given the previous finding that both ERK inhibition reduces M. bovis BCG 
and host cell survival, preliminary experiments were performed to investigate whether 
the ERK signalling affected apoptosis in macrophages following M. bovis BCG 
infection. An ATP detection based assay demonstrated that the macrophage viability 
of M. bovis BCG-infected cells was significantly reduced by treating the cell with ERK 
inhibitor (Figure 5-4A). However, this was not specifically associated with M. bovis 
BCG infection because a similar effect was observed in uninfected cells. 
To further examine whether the caspase-dependent mechanism was involved in the 
ERK inhibitor induced cell death, RAW264.7 macrophages were treated with 
SCH772894 for 1h then infected with BCG for another 24h and 48h in the presence of 
SCH772894. Caspase-3/-7 activation was detected by (Apo-ONE® Homogeneous 
Caspase-3/7). (Figure 5-4B) shows that the caspase-3 activation level induced by M. 
bovis BCG infection was similar to that in uninfected macrophages, which is consistent 
with previous studies have shown that while non-pathogenic mycobacteria induce 
apoptosis, virulent strains like BCG are able to inhibit caspase activation and apoptosis 
(Butler et al., 2012 and Keane et al., 2000). Using SCH772894 to inhibit ERK, a 
significantly higher level of caspase-3 level was observed in M. bovis BCG infected 
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cells and uninfected cells compared to cells treated with the DMSO vehicle alone. This 
correlated with a significant decrease in the number of viable cells.   
Thus, it appears that while ERK activity is associated with the inhibition of cell 
death and caspase activity in RAW264.7 macrophages, this inhibitory action may not 
be responsible for the previously published mycobacterial virulence phenotype of 
apoptosis inhibition. 
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Figure 5-4 ERK activity inhibits caspase activity and cell death in M. bovis BCG 
infected and uninfected RAW264.7 macrophages 
 
RAW264.7 cell were untreated or pretreated with SCH772984, then infected with M. 
bovis BCG at MOI of 10. (A) Macrophage viability was determined by Cell Titer Glo, 
ATP detection assay, at the time point indicated. (B) Cell lysates were collected at 24 
and 48h post infection, relative caspase-3/-7 activity of macrophages in the indicated 
Chapter 5        The Role of ERK, MNK, eIF4E phosphorylation on Mycobacterial Infection Pathogenesis 
  
152 
 
conditions was determined by Apo-ONE® Homogeneous Caspase-3/7 Assay. 
Cycloheximide treated cells was used as an assay positive control. Results represents 
the mean ± SEM from three independent triplicate experiments, *p ≤ 0.05. 
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5.6. DISCUSSION 
 
The primary site of M.tuberculosis infection is in the alveoli in the lung, where 
the bacilli are phagocytised by the alveolar macrophages. This initial infection event is 
followed by a recruitment of inflammatory cells and the production of regulatory 
cytokines such as TNFα and IL-10. 
TNFα was described by Mootoo et al. 2009, referring to its role in TB infection, 
as a double edged sword. It is a major pro-inflammatory cytokine and has the capacity 
to contain the infection by promoting granuloma formation. However, TNFα can also 
promote the growth of M. tubeculosis in human monocyte (Byrd, 1997, Silver et al., 
1998) and its sustained overproduction can lead to excessive inflammatory changes 
driving formation of the necrotic lesion that is necessary for transmission. TNFα 
inhibitors have been introduced to treat inflammatory diseases, such as rheumatoid 
arthritis and Crohn’s disease. Interestingly, several studies suggested that there may 
be a significant clinical benefit of using anti-TNF drugs in TB (Kindler et al., 1989, 
Wallis et al. 2004, Mayanja-Kizza et al., 2005, Mootoo et al., 2009). Thus, it has been 
hypothesised that selectively blocking the pro-inflammatory events induced by TNFα 
without disrupting the preformed granuloma may be a useful adjunct to conventional 
chemotherapy. Therefore, by understanding the upstream mechanisms of TNFα 
signalling, the discovery of new TNFα inhibitors would be highly beneficial in 
inflammatory diseases as well as TB. 
A study conducted by Andersson and Sundler, 2005, revealed that the LPS-
induced activation of ERK and p38 is integrated by MNK and that the signal stimulates 
translation of TNFα through the phosphorylation of eIF4E. Therefore, the production 
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of TNFα is controlled by a strong post-transcriptional regulation. To understand the 
effect of ERK and MNK on mycobacterium-induced TNFα production, the effect of 
ERK and MNK kinase inhibitors on TNFα secretion were investigated in murine 
macrophages (RAW264.7) upon challenge M. bovis BCG as well as LPS. When 
macrophages are stimulated with LPS or M. bovis BCG different signal transduction 
pathways are activated as LPS stimulates TLR4 and M. bovis BCG stimulates TLR2. 
Herein, both stimuli signal via ERK1/2 kinase to regulate translation of TNFα, through 
the downstream kinase MNK. TNFα production is inhibited by SCH772984 (ERK 
inhibitor) and CGP57380 (MNK inhibitor). This inhibition is paralleled by the inhibition 
of the phosphorylation of eIF4E, thus M. bovis BCG (and LPS) stimulate enhanced 
translation of TNFby signalling which culminates in phosphorylation of eIF4E. 
 
The role of ERK and MNK on IL-10 production in response to mycobacteria 
were also investigated because a previous study by Shaw et al., 2000 concluded that 
the anti- inflammatory cytokine IL-10 is secreted by macrophages in response to 
mycobacterial infection. In agreement with this, the results show that the levels of IL-
10 production are induced in RAW264.7 cells by M. bovis BCG infection significantly 
at 24h post infection. IL-10 is associated with a diminishing TNFα production in 
mycobacterial infection (Oswald et al., 1992, Murray et al., 1997), however a more 
recent study by O’Leary et al., 2010 as well as the results in this chapter indicate that 
IL-10 and TNFα production were positively correlated. 
Thus, as the production of IL-10 was inhibited by ERK inhibitor, as well as MNK 
inhibitor, these results suggest that eIF4E phosphorylation regulates IL-10 production 
in RAW264.7 macrophages. 
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The STAT3 signalling pathway provides one potential mechanism by which IL-
10 may arrest M. tuberculosis phagosome maturation in human macrophages 
(O’Leary et al., 2010). Thus, the effect of these kinases (ERK, MNK) on phagosomal 
acidification during M. bovis BCG were investigated.  In agreement with previous 
studies, the results showed convincingly that live, but not heat-killed, M. bovis BCG 
inhibited phagosome acidification. Moreover, this experiment provided evidence that 
the arrest of mycobacterial phagosomes is linked, at least in part, with the activation 
of ERK. It was also noticed that there was an increase in the number of cytoplasmic 
acidic vacuoles that were not co-localized with the bacilli, in M. bovis BCG-infected 
RAW264.7 cells treated with ERK inhibitor. Moreover, a previous study by Deretic, 
2004 demonstrated that stimulation of autophagy enhances mycobacterium 
phagosome maturation and suppresses intracellular survival of mycobacteria. 
Therefore, the expression of autophagy marker LC3 was investigated in M. bovis 
BCG-infected RAW264.7 cells with and without ERK inhibition.  It was demonstrated 
that pharmacological ERK inhibition induced autophagy in M. bovis BCG infected 
murine macrophages.  
Recent studies by Zullo et al., 2012, 2014 revealed that M. bovis BCG induced 
a weak autophagy response, which occurs independently of mTOR signalling. The 
results in the present study provide evidence to support the important role of ERK-
MAPK signalling in autophagy induction/inhibition. This pathway has been studied in 
cancer cells and it has been demonstrated that sustained activation impairs 
autophagy maturation (Corcelle et al., 2006, 2009). The results in this chapter are 
only preliminary and evaluation for the other autophagy regulatory proteins is needed 
to confirm this finding. 
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6. GENERAL CONCLUSION AND FUTURE WORK  
 
This study provides an insight on how post transcriptional changes effect the 
host immune response against Mycobacterium bovis BCG, used as a surrogate for 
Mycobacterium tuberculosis, the causative agent of tuberculosis (TB). It is the most 
successful bacterial pathogen which has developed different strategies for the 
modulation of the host immune system (Behar et al., 2010).  
Despite all the efforts to target and eliminate this chronic disease, tuberculosis 
remains a challenging major health problem. The long treatment duration and its 
association with various side effects often result in noncompliance of the patients and 
the emergence of drug-resistance TB. There is therefore a remaining urgent need to 
improve the treatment strategies of the disease as well as the effectiveness of the 
current treatments. This can be achieved by developing an adjunctive therapy that 
helps the host response to the disease (Kiran et al., 2015). Understanding the host-
mycobacterium interaction may help to improve our approach to the host-directed TB 
therapies possibly enhancing disease resolution, improving treatment outcomes and 
reducing duration of therapy. The development of host directed therapies will be 
expedited by further understanding of how this pathogen hijacks host cell processes 
to facilitate its survival. One of the key component in this process is the regulation of 
host gene expression. Indeed, the translation of mRNA, and its associated post-
transcriptional regulatory mechanisms, contributes to acute changes in the proteome 
allowing adaptation to rapid changes in the cell environment such as infections. This 
current study has demonstrated that how M. bovis BCG is capable of inducing 
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changes in translation initiation regulatory proteins and how these changes impact on 
host-pathogen interactions. 
 
The data presented using polysome profiling showed a reduction of polysomes 
abundance in RAW264.7 macrophages during infection, suggesting that infection 
results in impaired global translation. This blockade of translation is associated with 
eIF2α phosphorylation, as shown by immunoblotting and also correlates with an 
increase in ATF4 expression. This confirms that the phosphorylation of eIF2α and the 
subsequent inhibition of protein synthesis are important host defensive mechanisms 
to limit the replication of many RNA viruses (García et al., 2007), but reduce also 
mycobacterium survival as proposed previously (Choi et al., 2010). Two kinases have 
been shown to play roles in eIF2α phosphorylation during ER stress (PERK) and 
amino acid starvation (GCN2). Antibodies against PERK, GCN2 and their 
phosphorylated forms were used, but the given results were not exploitable. Overall,  
these results suggest that the control of eIF2 recycling could play a part in the 
translational control induced by M. bovis BCG and further studies should aim and 
demonstrating which pathways are responsible for this activation using 
pharmacological inhibitors of eIF2 kinases. Furthermore, to further quantify the extent 
of translational shut-off induced by M. bovis BCG, ribopuromycylation assays should 
be performed. These assays rely on the quantification of puromycin, acting as tRNA 
analog, incorporation into nascent peptide using immunoblotting and/or confocal 
microscopy.   
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Other major regulatory components of protein synthesis in eukaryotes are 
eIF4E and 4E-BP1. M. bovis BCG-infected RAW264.7 macrophages showed an 
induction of 4EBP1 phosphorylation level. Furthermore, phospho-kinases arrays 
demonstrated a significant increase in AKT phosphorylation, and a non-significant 
change in the phosphorylation level of its downstream target, mTOR and p70S6 
kinase. This in agreement with a previous studies demonstrate that M. bovis BCG 
induces a substantial mTOR activity and induces the phosphorylation of downstream 
substrate S6 kinase. However, no change in 4EBP1 phosphorylation status was 
observed during infection in this study, and this difference could be the result of a lower 
MOI used in their experiment (Zullo & Lee, 2012, Holla et al., 2016). Given the fact 
that dephosphorylated 4E-BPs bind to eIF4E to prevent its association with eIF4G 
(Pause et al., 1994), whereas the phosphorylation of 4EBPs, mediated by mTORC1, 
enhance the eIF4E availability and eIF4F complex association (Gingras et al., 1999, 
2001), the results presented in this thesis suggest that M. bovis BCG infection would 
not affect the availability of eIF4E and its ability to participate in cap binding. 
 
This thesis work also demonstrated that M. bovis BCG was able to induce a 
gradual increase in eIF4E phosphorylation throughout the infection. In comparison, 
stimulation with a TLR2/4 agonist only induced a rapid but short-lived eIF4E 
phosphorylation, while heat-killed BCG-induced eIF4E phosphorylation also occurred 
rapidly but declined later during infection. The induction of eIF4E activity is generally 
linked with an increased translation of a subset of mRNAs called eIF4E sensitive 
mRNA through mechanisms that remain elusive (Zimmer et al., 2000, Piccirillo et al., 
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2014). These subsets of eIF4E sensitive mRNAs are transcripts that contain relatively 
long and structured 5’ UTRs otherwise inefficiently translated mRNAs such as cyclin 
D1 mRNA, IRF7 mRNA, IκBα mRNA (Nandagopal et al., 2015). Furthermore, this 
thesis also investigated the effect of BCG infection on MAPK-MNK signaling pathways 
that regulate the phosphorylation of eIF4E on Ser209 (Pyronnet, 2000). Overall the 
results presented suggest that M. bovis BCG infection induces the phosphorylation of 
eIF4E via the activation of MNK and ERK as evidenced by the use of pharmacological 
kinase inhibitors and immunoblotting. Given the impact of M. bovis BCG infection on 
global translation and the role of eIF4E in selective translational control, further studies 
should adopt genome-wide approaches to identify which host mRNAs have induced 
or reduced association with polysomes during infection. This will reveal the full extent 
of translational remodelling exerted by M. bovis BCG on the infected host 
 
Both ERK1/2 and MNK1 phosphorylation were induced in M. bovis BCG -
infected RAW264.7 macrophages. The inhibition of MNK1 using a specific inhibitor 
CGP 57380 reverted the M. bovis BCG -induced eIF4E phosphorylation in RAW264.7 
cells. Previous study on MEFs lacking the ability to express phosphorylated eIF4E 
form have an increased transcriptional activity of N-κB, which in turn promotes the 
interferon- β (IFN-β) production. The interferon- β (IFN-β) has a protective role in viral 
infection as well as during mycobacterial infection. In 2005, Shi et al. reported that type 
I IFNs are required for macrophage production of inducible NO synthase, a product 
that is required for control of infection. Taken together these findings would suggest 
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an involvement of MNK/eIF4E pathway activation on the translational regulation 
of IFN-β production during mycobacterial infection. 
In contrast, the other arm of the MAPK pathway, p38MAPK was found to be 
activated only later during infection and its inhibition did not impact on the 
phosphorylation level of eIF4E, as indicated by using p38MAPK specific inhibitor. BCG 
survival was investigated as well, there was no effect on the number of recovered 
bacteria in the time period investigated in this project. Therefore the late activation of 
p38MAPK is most likely not linked to translational control via eIF4E during M. bovis 
BCG infection.  
Therefore, these results together point to the significance of the wide range 
effect exerted by the activation of different MAPK pathway members on eIF4E 
regulation during infection. These finding support a model in which M. bovis BCG 
benefits from the activated ERK-MNK-eIF4E signaling axis to survive inside the 
macrophage. 
 
In order to assess further this hypothesis and the impact of ERK-MNK signaling 
on the host-mycobacterium interaction, the level of M. bovis BCG -induced cytokine 
production was investigated by ELISA. TNFα plays a significant, although 
contradictory role in protecting the host against invading pathogens, yet harming the 
host through tissue damages induced by excessive pro-inflammatory immune 
response. Considering that TNFα is a major pro-inflammatory cytokine and its 
sustained overproduction can lead to excessive inflammatory changes and tissue 
damage, TNFα inhibitors have been introduced to treat inflammatory diseases, such 
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as rheumatoid arthritis and Crohn’s disease (Rowlett et al., 2007). In addition, it has 
been proposed that there may be a significant clinical benefit of using anti-TNF drugs 
in TB (Mootoo et al., 2009).  
In this thesis, the results demonstrate that M. bovis BCG, a potent TLR2 
agonist, induces gradual TNFα production. In contrast, the activation of TLR4 using 
LPS, a gram negative bacterial product, induces a rapid peaking TNFα production. 
This stimulatory effect on TNFα production is inhibited by the inhibition of ERK and 
MNK, using SCH772984 and CGP57380 respectively, proposing a regulatory role for 
the ERK-MNK-eIF4E pathway during infection. In addition, studies have suggested a 
clinical benefit from using TNFα suppressive agents as an anti-granuloma therapy in 
TB (Wallis et al., 2004, Mayanja-Kizza et al., 2005). Thus to develop new anti-TNFα 
drugs, MNK can be considered as a new target in the development of TB control 
strategies.  
Furthermore, the anti-inflammatory cytokine IL-10 production was induced 
concomitantly to the increase in TNFα production, suggesting that mycobacterial 
induction of ERK-MNK-eIF4E regulates both TNFα as well as IL-10 production. This 
is in agreement with previous studies which concluded that activation of the MAPK 
pathway is required for the expression of TNFα and, IL-10 during mycobacterium 
infection (Reiling et al., 2001, Schorey et al., 2003). Given that a previous study 
revealed that IL-10 induces mycobacterium survival in human macrophages 
(O'Leary.et al., 2011), these results, collectively, might suggest that M. bovis BCG-
induced eIF4E phosphorylation is beneficial for bacterial survival. Building on these 
results, further work should aim at measuring how infection, and the inhibition of ERK-
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MNK, impact widely on cytokines production by using cytokines panel arrays rather 
than focussing on IL10 and TNFα. 
 
To investigate the impact on phagocytosis, a colocalization experiment was 
conducted by using an acidotropic fluorescent dye that accumulates in acidic 
organelles, LysoTracker. The results show that blocking ERK-MAPK activity in 
infected RAW264.7 macrophages enhances M. bovis BCG and phago-lysosome 
colocalization 3h post infection. In contrast, no changes have been seen with MNK 
inhibitor-treated infected RAW264.7 macrophages. Another study by Fratti et al., 2003, 
highlighted the role of p38 activation in phagosomal maturation arrest during 
mycobacterial infection by showing that the pharmacological inhibition of p38 caused 
phagosomal acidification and enrichment of the late endocytic markers on the 
mycobacterial phagosome. Furthermore, the inhibition of ERK resulted in an increase 
in the number of acidic vacuoles in the cytoplasm that colocalize with the autophagy 
marker LC3, proposing that the increase in ERK-MAPK activity during M. bovis BCG 
infection contributes to the control of autophagy. 
 
The role of ERK-MAPK signaling and its impact on mycobacterial survival 
mechanism remains elusive. In a recently published report conducted by Richardson 
et al., 2015 showed that M. tuberculosis activates ERK signalling, promotes anti-
inflammatory macrophage responses and blunts Th1 responses against the pathogen. 
This report supports my results regarding the importance of ERK signalling. They 
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suggest the possibility of using selective ERK inhibitors as host-directed immuno-
therapeutics for tuberculosis. Finally, inhibition of ERK was associated with increase 
in caspase dependent cell death, so M. bovis BCG may elicit a prolonged low level of 
phosphorylated ERK to inhibit cellular apoptosis, which is considered as a microbicidal 
host mechanism. 
 
To summarize, upon challenge with mycobacterium, host cells attempt to mount 
an immune response to control the bacterial growth, while activating stress pathway 
to limit the cellular damage. This thesis work demonstrated that M. bovis BCG induces 
a global translational blockade that impairs immune response in murine macrophages, 
this effect is mediated through a pronounced phosphorylation of eIF2α. The cap-
binding protein eIF4E is phosphorylated on serine 209, which occurs via the activation 
of ERK-MAPK/MNK pathway but not p38 MAPK. Activation of ERK/MNK signalling is 
required for host cell survival. While very little is known about translational control by 
bacterial pathogens, including M. tuberculosis and how this contributes to 
pathogenesis. The results in chapter 5 provide an insight into the implication of 
ERK/MNK/eIF4E pathway on mycobacterial pathogenesis. We propose that induction 
of IL-10, phagosomal maturation arrest, autophagy modulation and caspase inhibition 
in M. bovis BCG infected murine macrophages are all driven by the activation of the 
extracellular signal-regulated kinases (ERK).  
Importantly, the data collected and presented in this manuscript have all been 
obtained using a surrogate pathogen in RAW264.7 murine macrophages. To really 
establish the potential importance of eIF4E phosphorylation for the control of M. 
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tuberculosis, future studies should aim at recapitulating the key findings in human 
THP-1 cells infected with M. bovis BCG and then with M. tuberculosis. Furthermore, 
while the importance of eIF4E phosphorylation was mostly assessed using 
pharmacological inhibitors of eIF4E upstream MAP kinases, it is important to directly 
demonstrate that eIF4E phosphorylation is required. To this end, future studies should 
make use of the eIF4ES209A/S209A mice developed by the Sonenberg lab. Using cells 
derived from mice overexpressing this non phosphorylable form of eIF4E will 
undoubtedly help to strengthen follow-up studies.   
 
In the future, a more complete understanding of macrophage-intrinsic ERK 
signalling and its outcomes may allow the design of host-directed therapies by 
interfering with this pathway and related immune evasion mechanisms to enhance 
protective immune functions in M. tuberculosis infection. 
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